Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	PPRC1 MYOD1 NACA HLF GATA1 TNIP1 RNF40 CAMTA2 POGZ DBP NR4A1 PTBP1 KDM6B RPRD1B NUFIP1 HOXA2 ZBED4 PTPRN NFATC3 NFE2L1 GLI2 GLIS2 MED26 UTF1 FOXJ1 FOXM1 ZFAT RPS6KA4 AIRE HES3 IL23A FOSL1 KANSL3 KMT2D USF3 ELL2 TNFRSF1A HCFC1 NPAS4 MYB	1.64e-06	1390	267	40	GO:0045944
GeneOntologyCellularComponent	chromatin	KLF8 MYOD1 HLF TSPYL2 GATA1 IST1 MCM2 RNF40 CAMTA2 POGZ DBP NR4A1 SRCAP ARID1A NUFIP1 HOXA2 ZBED4 NFATC3 NFE2 NFE2L1 PLK3 HOMEZ FOXJ1 FOXM1 TSPYL6 HES3 LHX6 DMBX1 PHC1 THAP7 FOSL1 KANSL3 TADA1 PRKAA1 SP6 ANKRD11 RORC PAX4 HCFC1 NPAS4	7.17e-06	1480	270	40	GO:0000785
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2 LRRC37A	1.12e-05	4	265	3	IPR029423
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2 LRRC37A	1.12e-05	4	265	3	PF14914
Domain	LRRC37	LRRC37A3 LRRC37A2 LRRC37A	1.12e-05	4	265	3	PF15779
Domain	LRRC37_N	LRRC37A3 LRRC37A2 LRRC37A	1.12e-05	4	265	3	IPR032754
Domain	LRRC37A/B-like	LRRC37A3 LRRC37A2 LRRC37A	1.12e-05	4	265	3	IPR015753
Domain	SH3	ARHGAP32 TSPOAP1 SH3GLB2 MYO15B SH3RF1 KALRN ARHGEF5 PPP1R13B ARHGAP9 MACF1 MAP3K21 ARHGAP33	6.33e-05	216	265	12	PS50002
Domain	SH3_domain	ARHGAP32 TSPOAP1 SH3GLB2 MYO15B SH3RF1 KALRN ARHGEF5 PPP1R13B ARHGAP9 MACF1 MAP3K21 ARHGAP33	7.55e-05	220	265	12	IPR001452
Domain	SH3_9	ARHGAP32 TSPOAP1 SH3GLB2 SH3RF1 ARHGEF5 MAP3K21 ARHGAP33	1.20e-04	78	265	7	PF14604
Domain	Tis11B_N	ZFP36L1 ZFP36L2	2.01e-04	2	265	2	PF04553
Domain	Tis11B_N	ZFP36L1 ZFP36L2	2.01e-04	2	265	2	IPR007635
Domain	DUF4414	REV1 HUWE1	2.01e-04	2	265	2	PF14377
Domain	ARHGEF5_35	ARHGEF5 ARHGEF35	2.01e-04	2	265	2	PF15441
Domain	ARHGEF5/35_N	ARHGEF5 ARHGEF35	2.01e-04	2	265	2	IPR029212
Domain	DUF4414	REV1 HUWE1	2.01e-04	2	265	2	IPR025527
Domain	-	RC3H1 ZFP36L1 ZFP36L2 UNKL ZC3H7B	2.43e-04	40	265	5	4.10.1000.10
Domain	DH_1	ARHGEF11 PLEKHG5 KALRN ARHGEF5 ARHGEF18 ARHGEF1	2.66e-04	63	265	6	PS00741
Domain	SH3	ARHGAP32 TSPOAP1 SH3GLB2 MYO15B SH3RF1 KALRN ARHGEF5 PPP1R13B ARHGAP9 MAP3K21 ARHGAP33	2.72e-04	216	265	11	SM00326
Domain	-	PTPRG SSH1 PTPRN TNS3 DUSP4 DUSP8 PTPN23	3.36e-04	92	265	7	3.90.190.10
Domain	RhoGEF	ARHGEF11 PLEKHG5 KALRN ARHGEF5 ARHGEF18 ARHGEF1	4.04e-04	68	265	6	SM00325
Domain	RhoGEF	ARHGEF11 PLEKHG5 KALRN ARHGEF5 ARHGEF18 ARHGEF1	4.73e-04	70	265	6	PF00621
Domain	DH_2	ARHGEF11 PLEKHG5 KALRN ARHGEF5 ARHGEF18 ARHGEF1	4.73e-04	70	265	6	PS50010
Domain	-	ARHGEF11 PLEKHG5 KALRN ARHGEF5 ARHGEF18 ARHGEF1	5.10e-04	71	265	6	1.20.900.10
Domain	DH-domain	ARHGEF11 PLEKHG5 KALRN ARHGEF5 ARHGEF18 ARHGEF1	5.10e-04	71	265	6	IPR000219
Domain	Prot-tyrosine_phosphatase-like	PTPRG SSH1 PTPRN TNS3 DUSP4 DUSP8 PTPN23	5.24e-04	99	265	7	IPR029021
Domain	DEATH	TNFRSF25 PIDD1 UNC5C TNFRSF1A	5.38e-04	27	265	4	SM00005
Domain	ZnF_C3H1	RC3H1 ZFP36L1 ZFP36L2 UNKL ZC3H7B	5.76e-04	48	265	5	SM00356
Domain	Tyr_Pase_AS	PTPRG SSH1 PTPRN DUSP4 DUSP8 PTPN23	5.93e-04	73	265	6	IPR016130
Domain	RGS-like_dom	ARHGEF11 ARHGEF1	5.96e-04	3	265	2	IPR015212
Domain	RGS-like	ARHGEF11 ARHGEF1	5.96e-04	3	265	2	PF09128
Domain	MAP1	MAP1A MAP1S	5.96e-04	3	265	2	IPR026074
Domain	zf-CCCH	RC3H1 ZFP36L1 ZFP36L2 UNKL ZC3H7B	6.34e-04	49	265	5	PF00642
Domain	BRLZ	HLF DBP NFE2 NFE2L1 FOSL1	8.35e-04	52	265	5	SM00338
Domain	BZIP_BASIC	HLF DBP NFE2 NFE2L1 FOSL1	9.11e-04	53	265	5	PS00036
Domain	BZIP	HLF DBP NFE2 NFE2L1 FOSL1	9.11e-04	53	265	5	PS50217
Domain	SEA	MUC17 ADGRF5 MUC16	9.16e-04	14	265	3	SM00200
Domain	bZIP	HLF DBP NFE2 NFE2L1 FOSL1	9.93e-04	54	265	5	IPR004827
Domain	-	MUC17 ADGRF5 MUC16	1.13e-03	15	265	3	3.30.70.960
Domain	Death	TNFRSF25 PIDD1 UNC5C TNFRSF1A	1.17e-03	33	265	4	PF00531
Domain	VDCC_a2/dsu	CACNA2D1 CACNA2D4	1.18e-03	4	265	2	IPR013680
Domain	VGCC_alpha2	CACNA2D1 CACNA2D4	1.18e-03	4	265	2	PF08473
Pathway	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	ARHGEF11 PLEKHG5 KALRN ARHGEF5 ARHGEF18 ARHGEF35 ARHGEF1	1.27e-05	59	188	7	M11215
Pathway	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	ARHGEF11 PLEKHG5 KALRN ARHGEF5 ARHGEF18 ARHGEF1	6.35e-05	52	188	6	MM14743
Pathway	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE	ARHGEF11 PLEKHG5 KALRN ARHGEF5 ARHGEF18 ARHGEF35 ARHGEF1	6.75e-05	76	188	7	M19832
Pathway	REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS	ARHGEF11 PLEKHG5 KALRN ARHGEF5 ARHGEF18 ARHGEF35 ARHGEF1	9.38e-05	80	188	7	M800
Pathway	REACTOME_RHOA_GTPASE_CYCLE	ARHGAP32 ARHGEF11 PLEKHG5 KALRN ARHGEF5 ARHGEF18 ARHGAP9 ARHGEF1 PKN2	1.20e-04	142	188	9	MM15576
Pathway	REACTOME_RHOA_GTPASE_CYCLE	ARHGAP32 ARHGEF11 PLEKHG5 KALRN ARHGEF5 ARHGEF18 ARHGAP9 ARHGEF1 PKN2	1.73e-04	149	188	9	M41805
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	STK36 SETD1B KIAA0513 PPRC1 RNF40 ITGA3 KDM6B SRCAP ARID1A ARHGEF11 DYSF CNTROB PLEKHG5 PLEKHM1 ITPR2 FOCAD MGAT1 ZBED4 SSH1 NF2 ZFP36L2 UNKL ZC3H7B PLK3 CRAMP1 WNK2 BAHCC1 DOC2A SEMA6B B4GALNT4 SH3RF1 KALRN SZT2 POLG TSNARE1 FBRSL1 RAPGEF1 NUP214 HUWE1 RASSF7 MICALL1 KANSL3 NHSL1 C2CD3 KMT2D MAP1S ADAMTS7 ANKRD11 PDCD11 CEP131 SH3BP5L LTBP3 HCFC1 PRRT4 ARHGAP33 RAI1	6.07e-29	1105	275	56	35748872
Pubmed	A census of human transcription factors: function, expression and evolution.	KLF8 MYOD1 HLF GATA1 CAMTA2 DBP NR4A1 HOXA2 ZBED4 ZFP36L1 ZFP36L2 NFATC3 NFE2 NFE2L1 GLI2 UNKL CRAMP1 HOMEZ FOXJ1 FOXM1 CENPT KIAA1549 AIRE HES3 LHX6 DMBX1 THAP7 FOSL1 MYPOP KMT2D USF3 SP6 RORC PAX4 MYB	1.28e-14	908	275	35	19274049
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	GAPVD1 NACA SH3GLB2 MCM2 RNF40 POGZ KDM6B PLEKHG5 HECW2 AMOTL2 ZC3H7B CRAMP1 WNK2 HOMEZ SZT2 KIF21A FBRSL1 KIAA1549 NUAK2 MICALL1 KANSL3 IBTK PDCD11 RAI1	8.23e-12	529	275	24	14621295
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	STK36 ARHGAP32 ERBB4 MAP1A TSPOAP1 APC2 TSPYL2 TP53INP2 NFE2L1 GLI2 TMEM59L PRRG4 LDLRAD4 WNK2 ATN1 ARHGEF5 TMEM151B ARHGEF18 NUP214 USF3 MAP1S	4.50e-11	430	275	21	35044719
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	PRSS2 SETD1B MAP1A SH3GLB2 TNIP1 RNF40 SRCAP ARID1A NFATC3 ARID5B FAM135A FOXM1 SH3RF1 TTC28 FBRSL1 PPP1R13B TACC2 HUWE1 KANSL3 BRF1 MACF1 CEP131 SH3BP5L	4.20e-10	588	275	23	38580884
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SETD1B KIAA0513 ZFYVE16 TSPOAP1 PPRC1 IST1 CAMTA2 POGZ FOCAD ZBED4 DENND4B TTC28 DLGAP4 NUP214 GIGYF2 MACF1 SH3BP5L SCRIB	5.39e-09	407	275	18	12693553
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ARHGAP32 GAPVD1 ERBB4 ZFP36L1 ZFP36L2 NFATC3 TNS3 WDR62 SH3RF1 TTC28 ARHGEF5 STIL RASSF7 NUAK2 MICALL1 NHSL1 C2CD3 ARHGEF1 ANKRD11 GIGYF2 MACF1 CEP131 SH3BP5L SCRIB MAP3K21 MTSS2	6.81e-09	861	275	26	36931259
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	GAPVD1 LRRC37A3 SH3GLB2 NR4A1 CNTROB PLEKHG5 NF2 NFATC3 NFE2L1 AGL DMBT1 AMOTL2 GTPBP3 MED26 PRRC2A LDLRAD4 CENPT POLG SEC31A BRF1 ARHGEF1 UNC5C GIGYF2 TJAP1 CEP131 LTBP3 MYB	7.01e-09	925	275	27	28986522
Pubmed	A human MAP kinase interactome.	ARHGAP32 MAP1A POGZ ARHGEF11 WNK2 SH3RF1 MKNK2 PPP1R13B RAPGEF1 PTPN23 NUP214 SEC31A USF3 ARHGEF1 GIGYF2 MACF1 SH3BP5L MAP3K21 ARHGAP33	1.47e-08	486	275	19	20936779
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	GAPVD1 PIDD1 SSPOP ITPR2 FOCAD TMCO4 MYO15B ZBED4 MOGS HECW2 AGL DENND4B ARID5B AMOTL2 KIF21A ARHGAP9 TSPYL6 HUWE1 FRY PCIF1 SCRIB RAI1 CXCR2	2.83e-08	736	275	23	29676528
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	TNFRSF25 DCHS2 PPRC1 APC2 TSPYL2 IST1 SH3GLB2 RNF40 POGZ KDM6B ARID1A NUFIP1 FOCAD NF2 SUPV3L1 ARID5B AMOTL2 PRRC2A TTC28 KALRN POLG KIF21A AIRE SEC31A HUWE1 SHROOM2 FRY MAP1S MACF1 LTBP3 SCRIB	4.17e-08	1285	275	31	35914814
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ARHGAP32 APC2 ARHGEF11 RTN1 SSH1 NFATC3 PRRC2A WNK2 CACNA2D1 PRR36 KALRN ZNRD2 KIF21A DLGAP4 ARHGEF18 SEC31A HUWE1 SHISA7 FRY GIGYF2 TJAP1 MACF1 CEP131 SCRIB RAI1 MTSS2	6.37e-08	963	275	26	28671696
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	STK36 ARHGAP32 ARHGEF11 SSPOP BAHCC1 SH3RF1 TTC28 KIAA1549 MACF1 MAST3	9.39e-08	130	275	10	12421765
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	SSH1 HECW2 RTL9 FAM135A CRAMP1 HOMEZ DNAH1 KANSL3 NHSL1 IBTK	4.31e-07	153	275	10	10718198
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	GAPVD1 TNIP1 POGZ SRCAP ARID1A NF2 AMOTL2 PRRC2A TTC28 PPP1R13B PTPN23 HUWE1 KMT2D PDCD11 GIGYF2 PKN2 SCRIB HCFC1	4.78e-07	549	275	18	38280479
Pubmed	Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis.	IL17RA IL23A CXCR2	4.89e-07	3	275	3	24442441
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	ARID1A CNTROB ZBED4 NF2 NFE2L1 AMOTL2 PRRC2A TNS3 TMEM151B HUWE1 ANKRD11 MACF1 SCRIB EIF3G	4.92e-07	332	275	14	37433992
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	KLF8 MYOD1 GATA1 POGZ SRCAP ARID1A NUFIP1 ZBED4 ZFP36L1 ZFP36L2 NFE2L1 GLIS2 ARID5B UTF1 FOXM1 AIRE DMBX1 PHC1 THAP7 IBTK ZNF277 MYB	5.96e-07	808	275	22	20412781
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	GAPVD1 SH3GLB2 ARID1A CNTROB NF2 ZFP36L2 AMOTL2 WDR62 SH3RF1 TTC28 KIAA1549 PPP1R13B MAP1S GIGYF2 CEP131 MAP3K21	6.50e-07	446	275	16	24255178
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	ARHGAP32 GAPVD1 ZFYVE16 IST1 SH3GLB2 NF2 PPP1R37 CRYBG1 SH3RF1 PPP1R13B NUP214 MICALL1 NHSL1 GIGYF2 MACF1 PKN2 SCRIB HCFC1	7.23e-07	565	275	18	25468996
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	GAPVD1 MAP1A RTN1 TNS3 WDR62 TTC28 NHSL1 IBTK MACF1 CEP131 SCRIB	9.91e-07	209	275	11	36779422
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	GAPVD1 MCM2 POGZ RPRD1B SSH1 PRRC2A WDR62 HOMEZ FOXM1 ATN1 NUP214 HUWE1 MICALL1 KANSL3 KMT2D MAP1S GIGYF2 TJAP1 PKN2 SCRIB EIF3G	1.15e-06	774	275	21	15302935
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	GATA1 POGZ NR4A1 ARID1A NFE2L1 GLI2 FOXM1 SH3RF1 TACC2 TUT1 DMBX1 PHC1 THAP7 IBTK SP6 MACF1 RORC PAX4 ZBTB3 NPAS4	1.15e-06	709	275	20	22988430
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	TSPYL2 MCM2 ARID1A CNTROB SSH1 RTL9 CRYBG1 TRMT1L TTC28 NUP214 HUWE1 IBTK KMT2D BSCL2 EIF3G HCFC1	1.25e-06	469	275	16	27634302
Pubmed	Genetic interaction mapping in mammalian cells using CRISPR interference.	SETD1B MCM2 SRCAP ARID1A PHC1 KMT2D HCFC1	1.27e-06	69	275	7	28481362
Pubmed	Human transcription factor protein interaction networks.	ARHGAP32 KLF8 MYOD1 RC3H1 NACA GATA1 TNIP1 POGZ SRCAP ARID1A NFATC3 GLI2 ARID5B TRMT1L PRRC2A HOMEZ ATN1 FBRSL1 PPP1R13B NUP214 LHX6 KANSL3 KMT2D TADA1 PDCD11 GIGYF2 CEP131 EIF3G HCFC1 MYB	1.29e-06	1429	275	30	35140242
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	ARHGAP32 GAPVD1 ZFYVE16 ARID1A FAM135A SH3RF1 TTC28 KIAA1549 PPP1R13B GIGYF2 MACF1 SCRIB	1.44e-06	263	275	12	34702444
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	GAPVD1 ZFYVE16 TNIP1 RNF40 POGZ ARID5B WDR62 HOMEZ TTC28 NUP214 HUWE1 PHC1 KMT2D GIGYF2 CEP131	1.46e-06	418	275	15	34709266
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	ARHGAP32 ERBB4 MCM2 NF2 DENND4B PPP1R37 FAM135A DLGAP4 PPP1R13B SEC31A NHSL1 UNC5C MACF1 SCRIB MTSS2	1.59e-06	421	275	15	36976175
Pubmed	Primate segmental duplication creates novel promoters for the LRRC37 gene family within the 17q21.31 inversion polymorphism region.	LRRC37A3 LRRC37A2 LRRC37A	1.94e-06	4	275	3	22419166
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	KIAA0513 LRRC37A3 PPRC1 SSPOP CEP68 LRRC37A ARHGEF18 MAST3	1.98e-06	105	275	8	9628581
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	ARHGAP32 TSPYL2 IST1 TNIP1 NR4A1 PTBP1 SSPOP CNTROB RUNDC3A PTPRN ZC3H7B GTPBP3 PRRC2A WNK2 ATN1 KALRN BRF1 ZNF277	2.04e-06	608	275	18	16713569
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	GAPVD1 CENPN PPRC1 CAMTA2 SRCAP RPRD1B NF2 NFE2L1 ARID5B CRYBG1 FAM135A POLG ARHGEF18 PTPN23 TACC2 SEC31A IRGQ HUWE1 SHROOM2 COL18A1 ARHGEF1 VCAN UNC5C PRKAA1 MACF1	2.05e-06	1084	275	25	11544199
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	MYOD1 HLF GATA1 MCM2 DBP HOXA2 ZFP36L1 NFATC3 NFE2 NFE2L1 UTF1 FOXJ1 FOXM1 THAP7 FOSL1 BRF1 ZNF277 RORC ZBTB3 HCFC1 RAI1 MYB	2.28e-06	877	275	22	20211142
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	STK36 ARHGAP32 RC3H1 TNIP1 CEP68 MYO15B SSH1 ADGRF5 FAM135A SH3RF1 GRAMD1A ARHGEF18 PTPN23 USF3 MACF1 MAST3	2.38e-06	493	275	16	15368895
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	KLF8 TSPYL2 ARID1A SSPOP PLEKHM1 TMCO4 PTPRG NF2 GLI2 ARID5B CRAMP1 WNK2 FAM149A SPATA6 POLG TSNARE1 FBRSL1 ARHGEF18 HUWE1 SHROOM2 DNAH1 KANSL3 COL18A1 USF3 ANKRD11 TJAP1 MACF1 BSCL2 SYTL1 RAI1	2.95e-06	1489	275	30	28611215
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ARHGAP32 ZFYVE16 ARID1A CNTROB ITPR2 PTPRG SSH1 NF2 PTPRN PPP1R37 PRRC2A TNS3 DUSP4 GRAMD1A DUSP8 KIAA1549 PPP1R13B PTPN23 HUWE1 NHSL1 C2CD3 KMT2D CEP131 SCRIB	3.79e-06	1049	275	24	27880917
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ARHGAP32 KCTD13 MAP1A PTBP1 ARID1A ARHGEF11 PLEKHG5 RTN1 ITPR2 HECW2 AJM1 DNAH6 PRRC2A WNK2 CACNA2D1 PRR36 KALRN DLGAP4 KIAA1549 SHROOM2 NUAK2 NHSL1 MAP1S ARHGEF1 CRACDL VCAN PRKAA1 MACF1 SCRIB	3.90e-06	1431	275	29	37142655
Pubmed	Brf1 posttranscriptionally regulates pluripotency and differentiation responses downstream of Erk MAP kinase.	ZFP36L1 ZFP36L2 BRF1	4.83e-06	5	275	3	24733888
Pubmed	Networks of bZIP protein-protein interactions diversified over a billion years of evolution.	HLF DBP NFE2 NFE2L1 FOSL1	1.56e-05	40	275	5	23661758
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	ARHGAP32 GAPVD1 ZFYVE16 FAM135A PRRC2A SH3RF1 TTC28 PTPN23 NUP214 SEC31A MICALL1 GIGYF2 MACF1 PKN2 SCRIB EIF3G MAP3K21 HCFC1	1.62e-05	708	275	18	39231216
Pubmed	The HECT type ubiquitin ligase NEDL2 is degraded by anaphase-promoting complex/cyclosome (APC/C)-Cdh1, and its tight regulation maintains the metaphase to anaphase transition.	SRCAP DYSF HECW2 RTL9 ZC3H7B RPS6KA4 MICALL1 MAP1S MACF1 PKN2 RAI1	1.67e-05	281	275	11	24163370
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	TP53INP2 PLEKHM1 UNKL CRAMP1 WNK2 TNS3 ZFAT RPS6KA4 KALRN SHROOM2	1.85e-05	233	275	10	37704626
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	ZFYVE16 KDM6B SRCAP ARHGEF11 PLEKHM1 HUWE1 PCDHGA8	1.98e-05	104	275	7	9205841
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	MYOD1 HLF GATA1 DBP NR4A1 HOXA2 NFATC3 NFE2 GLI2 GLIS2 LHX6 DMBX1 FOSL1 RORC PAX4	3.32e-05	544	275	15	28473536
Pubmed	Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.	ARHGAP32 JPH4 MAP1A NF2 ARID5B MROH7 TRMT1L MAGEC1 ZC3H7B PRRC2A HUWE1 DNAH1 FAM222A MACF1	4.73e-05	496	275	14	31343991
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	GAPVD1 SETD1B TSPYL2 MCM2 RNF40 SRCAP ARID1A RPRD1B ITPR2 TRMT1L NUP214 HUWE1 SCRIB	5.56e-05	440	275	13	34244565
Pubmed	Evolutionary dynamism of the primate LRRC37 gene family.	LRRC37A3 LRRC37A2 LRRC37A	5.63e-05	10	275	3	23064749
Pubmed	NEDD4L-mediated Merlin ubiquitination facilitates Hippo pathway activation.	NF2 AMOTL2 HUWE1	5.63e-05	10	275	3	33058421
Pubmed	Prediction of the coding sequences of mouse homologues of FLJ genes: the complete nucleotide sequences of 110 mouse FLJ-homologous cDnas identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DYSF NFE2L1 SLC27A3 ARHGEF1 LTBP3 SYTL1	6.00e-05	85	275	6	15449545
Pubmed	Myb promotes centriole amplification and later steps of the multiciliogenesis program.	FOXJ1 MYB	6.23e-05	2	275	2	24048590
Pubmed	Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia.	ZFP36L1 ZFP36L2	6.23e-05	2	275	2	20622884
Pubmed	Rho GEF Lsc is required for normal polarization, migration, and adhesion of formyl-peptide-stimulated neutrophils.	ARHGEF11 ARHGEF1	6.23e-05	2	275	2	16263795
Pubmed	ARID1A loss activates MAPK signaling via DUSP4 downregulation.	ARID1A DUSP4	6.23e-05	2	275	2	38071325
Pubmed	Attenuation of AMPK signaling by ROQUIN promotes T follicular helper cell formation.	RC3H1 PRKAA1	6.23e-05	2	275	2	26496200
Pubmed	An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals.	IL17RA CXCR2	6.23e-05	2	275	2	17202320
Pubmed	Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FOXM1 signaling cascade.	FOXM1 PRKAA1	6.23e-05	2	275	2	23819460
Pubmed	The effects of GATA-1 and NF-E2 deficiency on bone biomechanical, biochemical, and mineral properties.	GATA1 NFE2	6.23e-05	2	275	2	23359245
Pubmed	Genetic analysis of hierarchical regulation for Gata1 and NF-E2 p45 gene expression in megakaryopoiesis.	GATA1 NFE2	6.23e-05	2	275	2	20351175
Pubmed	Enhanced binding of HLF/DBP heterodimers represents one mechanism of PAR protein transactivation of the factor VIII and factor IX genes.	HLF DBP	6.23e-05	2	275	2	10073576
Pubmed	HUWE1 ubiquitinates MyoD and targets it for proteasomal degradation.	MYOD1 HUWE1	6.23e-05	2	275	2	22277673
Pubmed	Clinical significance of syndecan-1 and versican expression in human epithelial ovarian cancer.	SDC1 VCAN	6.23e-05	2	275	2	20204274
Pubmed	Histone demethylase JMJD3 downregulation protects against aberrant force-induced osteoarthritis through epigenetic control of NR4A1.	NR4A1 KDM6B	6.23e-05	2	275	2	35831280
Pubmed	Nuclear hormone receptors in T lymphocytes.	NR4A1 RORC	6.23e-05	2	275	2	11983153
Pubmed	Identification of pancreatic juice proteins as biomarkers of pancreatic cancer.	PRSS2 CELA3B	6.23e-05	2	275	2	20428826
Pubmed	Gene-gene interactions in IL23/Th17 pathway contribute to psoriasis susceptibility in Chinese Han population.	IL17RA IL23A	6.23e-05	2	275	2	22909235
Pubmed	Potential for immunotherapy with heat-killed Mycobacterium vaccae in respiratory medicine.	TNFRSF1A CXCR2	6.23e-05	2	275	2	20635912
Pubmed	ErbB4 reduces synaptic GABAA currents independent of its receptor tyrosine kinase activity.	ERBB4 NRG2	6.23e-05	2	275	2	24218551
Pubmed	Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics.	ERBB4 NRG2	6.23e-05	2	275	2	33378376
Pubmed	Mice lacking transcription factor NF-E2 provide in vivo validation of the proplatelet model of thrombocytopoiesis and show a platelet production defect that is intrinsic to megakaryocytes.	GATA1 NFE2	6.23e-05	2	275	2	9716588
Pubmed	Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology.	IL23A RORC	6.23e-05	2	275	2	20393462
Pubmed	Hematopoietic-specific activators establish an overlapping pattern of histone acetylation and methylation within a mammalian chromatin domain.	GATA1 NFE2	6.23e-05	2	275	2	12379744
Pubmed	IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells.	IL23A RORC	6.23e-05	2	275	2	22772566
Pubmed	Inter-conversion of neuregulin2 full and partial agonists for ErbB4.	ERBB4 NRG2	6.23e-05	2	275	2	17945187
Pubmed	Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis.	TNIP1 IL23A	6.23e-05	2	275	2	21623003
Pubmed	IL-23 is required for protection against systemic infection with Listeria monocytogenes.	IL17RA IL23A	6.23e-05	2	275	2	19923464
Pubmed	ZFP36L1 and ZFP36L2 inhibit cell proliferation in a cyclin D-dependent and p53-independent manner.	ZFP36L1 ZFP36L2	6.23e-05	2	275	2	29426877
Pubmed	Regulated localization is sufficient for hormonal control of regulator of G protein signaling homology Rho guanine nucleotide exchange factors (RH-RhoGEFs).	ARHGEF11 ARHGEF1	6.23e-05	2	275	2	24855647
Pubmed	CD138 expression is a molecular signature but not a developmental requirement for RORγt+ NKT17 cells.	SDC1 RORC	6.23e-05	2	275	2	34549726
Pubmed	Scribble modulates the MAPK/Fra1 pathway to disrupt luminal and ductal integrity and suppress tumour formation in the mammary gland.	FOSL1 SCRIB	6.23e-05	2	275	2	24852022
Pubmed	Improving mRNA 5' coding sequence determination in the mouse genome.	APC2 MKNK2	6.23e-05	2	275	2	24504701
Pubmed	Arhgef1 Plays a Vital Role in Platelet Function and Thrombogenesis.	ARHGEF11 ARHGEF1	6.23e-05	2	275	2	30994039
Pubmed	Megakaryocyte-osteoblast interaction revealed in mice deficient in transcription factors GATA-1 and NF-E2.	GATA1 NFE2	6.23e-05	2	275	2	15005853
Pubmed	Muscle-specific deletion of Arid5b causes metabolic changes in skeletal muscle that affect adipose tissue and liver.	MYOD1 ARID5B	6.23e-05	2	275	2	36743919
Pubmed	Characterization of DeltaN-Zfp36l2 mutant associated with arrest of early embryonic development and female infertility.	ZFP36L1 ZFP36L2	6.23e-05	2	275	2	22367205
Pubmed	Nuclear accumulation of glioma-associated oncogene 2 protein and enhanced expression of forkhead-box transcription factor M1 protein in human hepatocellular carcinoma.	GLI2 FOXM1	6.23e-05	2	275	2	20712011
Pubmed	IL-23 Promotes a Coordinated B Cell Germinal Center Program for Class-Switch Recombination to IgG2b in BXD2 Mice.	IL17RA IL23A	6.23e-05	2	275	2	32554431
Pubmed	c-Myb and GATA-1 alternate dominant roles during megakaryocyte differentiation.	GATA1 MYB	6.23e-05	2	275	2	21668739
Pubmed	Structural basis of PDZ-mediated chemokine receptor CXCR2 scaffolding by guanine nucleotide exchange factor PDZ-RhoGEF.	ARHGEF1 CXCR2	6.23e-05	2	275	2	28179147
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	PRSS2 SETD1B KCTD13 RC3H1 APC2 RNF40 ARID1A SSH1 NFE2 NFE2L1 HECW2 PLK3 WNK2 RPS6KA4 DUSP4 PCSK7 HCFC1	8.20e-05	730	275	17	34857952
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	GAPVD1 ZFYVE16 NACA RNF40 RTN1 ITPR2 TNS3 WDR62 TTC28 ARHGEF18 NUP214 HUWE1 IBTK CEP131 SH3BP5L EIF3G HCFC1	8.62e-05	733	275	17	34672954
Pubmed	Interactome mapping of the phosphatidylinositol 3-kinase-mammalian target of rapamycin pathway identifies deformed epidermal autoregulatory factor-1 as a new glycogen synthase kinase-3 interactor.	RC3H1 NR4A1 ARHGEF11 WDR62 THAP7 PRKAA1	9.34e-05	92	275	6	20368287
Pubmed	STK11 is required for the normal program of ciliated cell differentiation in airways.	FOXJ1 NUAK2 PRKAA1 MYB	1.02e-04	31	275	4	31636950
Pubmed	Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes.	SETD1B KMT2D HCFC1	1.02e-04	12	275	3	27563068
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	MAP1A CNTROB ARHGEF18 STIL C2CD3 KMT2D GIGYF2 CEP131	1.16e-04	184	275	8	32908313
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	ARHGAP32 ERBB4 KCTD13 MAP1A KIAA0513 TSPOAP1 NACA PTBP1 RTN1 AJM1 WNK2 KALRN GRAMD1A DLGAP4 TACC2 HUWE1 SHROOM2 SHISA7 NHSL1 MAP1S MACF1 CEP131	1.20e-04	1139	275	22	36417873
Pubmed	POGZ Is Required for Silencing Mouse Embryonic β-like Hemoglobin and Human Fetal Hemoglobin Expression.	GATA1 POGZ NFE2	1.32e-04	13	275	3	29898395
Pubmed	Temporally divergent regulatory mechanisms govern neuronal diversification and maturation in the mouse and marmoset neocortex.	APC2 HLF NR4A1	1.32e-04	13	275	3	35915179
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	PRSS2 ARHGAP32 NACA MCM2 ARHGEF11 PLEKHG5 PRRC2A PRR36 ZNRD2 ARHGEF5 ARHGEF18 ARHGAP9 NUP214 HUWE1 ARHGEF1 SP6 SCRIB EIF3G ARHGAP33	1.43e-04	916	275	19	32203420
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	SETD1B CENPN RPRD1B ZBED4 MOGS NF2 SLC12A9 ZFP36L2 ARID5B NPAP1 UNKL CRAMP1 FOXM1 ZFAT SZT2 TMEM151B NUP214 SEC31A TADA1 BRF1 ANKRD11 GIGYF2 C9orf50 CXCR2	1.59e-04	1327	275	24	32694731
Interaction	TOP3B interactions	STK36 SETD1B KIAA0513 PPRC1 RNF40 ITGA3 KDM6B SRCAP ARID1A ARHGEF11 DYSF CNTROB PLEKHG5 PLEKHM1 ITPR2 FOCAD MGAT1 ZBED4 MOGS SSH1 NF2 ZFP36L2 UNKL ZC3H7B PRRC2A PLK3 CRAMP1 WNK2 BAHCC1 DOC2A SEMA6B B4GALNT4 SH3RF1 KALRN SZT2 POLG TSNARE1 FBRSL1 RAPGEF1 NUP214 HUWE1 RASSF7 MICALL1 KANSL3 NHSL1 IBTK C2CD3 KMT2D MAP1S ADAMTS7 ANKRD11 PDCD11 CEP131 SH3BP5L LTBP3 HCFC1 PRRT4 ARHGAP33 RAI1	1.88e-14	1470	271	59	int:TOP3B
Interaction	YWHAH interactions	ARHGAP32 GAPVD1 KCTD13 MCM2 PLEKHG5 SSH1 ZFP36L1 ZFP36L2 NFATC3 AMOTL2 WNK2 TNS3 WDR62 HOMEZ RPS6KA4 SH3RF1 TTC28 ARHGEF5 HUWE1 STIL RASSF7 NUAK2 MICALL1 NHSL1 C2CD3 PRKAA1 ANKRD11 GIGYF2 MACF1 CEP131 SH3BP5L SCRIB MAP3K21 MAST3 MTSS2	2.10e-06	1102	271	35	int:YWHAH
Interaction	GSK3A interactions	GAPVD1 MAP1A LRRC37A2 PTBP1 ARHGEF11 CNTROB RTN1 CRYBG1 TNS3 WDR62 FOXM1 TTC28 KIF21A MKNK2 NHSL1 IBTK MACF1 CEP131 SCRIB	1.85e-05	464	271	19	int:GSK3A
Interaction	ZZZ3 interactions	KLF8 SETD1B MYOD1 GATA1 HECW2 ATN1 PPP1R13B KANSL3 TADA1 HCFC1	1.90e-05	139	271	10	int:ZZZ3
Cytoband	Ensembl 112 genes in cytogenetic band chr19p13	NFILZ APC2 PTBP1 REEP6 TMEM59L GTPBP3 MED26 SEMA6B FBXW9 PRR36 MKNK2 MUC16 ARHGEF18 MAP1S EIF3G MAST3	3.01e-05	797	275	16	chr19p13
Cytoband	11p15.5	CDKN1C PIDD1 B4GALNT4 DUSP8 RASSF7 SYT8	8.22e-05	118	275	6	11p15.5
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ARHGEF11 KALRN ARHGEF5 ARHGEF18 ARHGEF35 ARHGEF1	4.24e-05	66	175	6	722
GeneFamily	PAR bZIP family	HLF DBP	2.78e-04	3	175	2	1248
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	KCTD13 PPRC1 PTBP1 SRCAP ARHGEF11 CNTROB MOGS SLC12A9 DENND4B ZC3H7B PRRC2A SEMA6B TEPSIN ATN1 SZT2 FBRSL1 NUP214 RASSF7 MICALL1 MYPOP KMT2D SH3BP5L HCFC1 MTSS2	1.82e-13	338	273	24	M17094
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN	CDKN1C STK36 TNFRSF25 KCTD13 SH3GLB2 DYSF PLEKHM1 MOGS SLC12A9 ZFP36L2 GTPBP3 SLC27A3 TEPSIN FBXW9 POLG GRAMD1A MKNK2 AIRE RAPGEF1 NUAK2 DNAH1 CACNA2D4 ANKRD11 PCSK7 TJAP1 CEP131 HCFC1 ARHGAP33 MAST3 RAI1	2.61e-08	905	273	30	M40865
Coexpression	LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS	NR4A1 PTPRG ZFP36L1 ARID5B ADGRF5 TNS3 CACNA2D1 TTC28 KALRN LAMA2 ELL2 UNC5C ANKRD11	4.78e-08	177	273	13	M39245
Coexpression	ESC_V6.5_UP_EARLY.V1_UP	TMCO4 DOC2A SH3RF1 MARCHF9 KIF21A AIRE PTPN23 SYT8 CEP131 MAST3 RAI1 MYB	1.88e-07	166	273	12	M2770
Coexpression	WONG_ADULT_TISSUE_STEM_MODULE	CDKN1C ARHGAP32 HLF DBP NR4A1 HOXA2 GLIS2 CRYBG1 SDC1 CACNA2D1 TTC28 ARHGEF5 DUSP4 DUSP8 LAMA2 PPP1R13B PHC1 COL18A1 ELL2 UNC5C MACF1 LTBP3 RAI1	2.29e-06	721	273	23	M1999
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN	TNFRSF25 SETD1B SH3GLB2 MOGS ZFP36L2 GTPBP3 SLC27A3 TEPSIN POLG GRAMD1A MKNK2 AIRE ARHGAP9 DNAH1 CACNA2D4 ANKRD11 PCSK7 TJAP1 HCFC1 ARHGAP33 RAI1	3.59e-06	634	273	21	M40866
Coexpression	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	TNFRSF25 TSPOAP1 TNIP1 PTBP1 PRRC2A TEPSIN SZT2 RAPGEF1 NUP214 TJAP1 HCFC1	3.95e-06	184	273	11	M19988
Coexpression	TRAVAGLINI_LUNG_CAPILLARY_INTERMEDIATE_1_CELL	TNIP1 ITGA3 PCDH12 ZFP36L1 HECW2 ADGRF5 DLGAP4 NUAK2 FRY TNFRSF1A	6.58e-06	158	273	10	M41666
Coexpression	WELCSH_BRCA1_TARGETS_DN	MCM2 MOGS PRRC2A POLG NUP214 RASSF7 PDCD11 SCRIB HCFC1	1.79e-05	141	273	9	M2428
Coexpression	LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES	NR4A1 PTPRG ZFP36L1 ARID5B CACNA2D1 TTC28 KALRN COL18A1 FRY	3.78e-05	155	273	9	M39246
Coexpression	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN	ST20-AS1 CETP NR4A1 CEP68 SSH1 UNKL KIF21A DUSP4 IL23A ANKRD11	4.08e-05	195	273	10	M9808
Coexpression	GARY_CD5_TARGETS_UP	DOK3 SH3GLB2 DBP KDM6B ARID1A ZFP36L1 ZFP36L2 NFE2L1 PRRC2A MARCHF9 GRAMD1A MKNK2 MAP1S ZNF277 ANKRD11 PKN2	4.13e-05	473	273	16	M17693
Coexpression	GSE11924_TFH_VS_TH17_CD4_TCELL_UP	ZFYVE16 UNKL WDR62 DUSP4 MKNK2 KMT2D ARSA VCAN PCSK7 MAST3	4.84e-05	199	273	10	M3156
Coexpression	GSE13306_TREG_RA_VS_TCONV_RA_DN	RTN1 ADGRF5 B4GALNT4 CENPT FBXW9 POM121L2 NHSL1 COL18A1 FRY PAX4	5.05e-05	200	273	10	M3227
Coexpression	GSE14350_IL2RB_KO_VS_WT_TEFF_DN	MCM2 FOCAD MGAT1 GTPBP3 TACC2 SHROOM2 TG LAT VCAN ARHGAP33	5.05e-05	200	273	10	M3424
Coexpression	PEREZ_TP53_TARGETS	CDKN1C GGT6 APC2 PIDD1 GASK1B LRRC37A GLIS2 UNKL TREML1 CRAMP1 LDLRAD4 FAM149A KALRN ZNRD2 FBRSL1 NRG2 KIAA1549 IRGQ LHX6 SHROOM2 COL18A1 FRY ADAMTS7 CRACDL VCAN LTBP3 MYB MTSS2	6.30e-05	1201	273	28	M4391
Coexpression	LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES	PTPRG HECW2 ADGRF5 LDLRAD4 CACNA2D1 TTC28 KALRN MACF1	9.81e-05	137	273	8	M39241
Coexpression	GSE21033_1H_VS_12H_POLYIC_STIM_DC_UP	RNF40 NR4A1 RPRD1B MGAT1 NFATC3 TACC2 RORC SCRIB MYB	1.01e-04	176	273	9	M7725
Coexpression	GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN	SETD1B CAMTA2 ARID1A MED26 GRAMD1A MUC16 KMT2D ARHGEF1	1.09e-04	139	273	8	M8948
Coexpression	KRIEG_HYPOXIA_NOT_VIA_KDM3A	CCDC9B KIAA0513 TNIP1 ITGA3 GLIS2 IL17RA SDC1 CRAMP1 DOC2A FOXM1 B4GALNT4 MARCHF9 POLG FBRSL1 RAPGEF1 RASSF7 ELL2 LAT PCIF1 MAP3K21	1.20e-04	746	273	20	M2469
Coexpression	TRAVAGLINI_LUNG_NEUTROPHIL_CELL	DOK3 KDM6B DYSF TP53INP2 NFE2 IL17RA PLK3 MKNK2 ARHGAP9 ARHGEF1 TNFRSF1A MAST3 CXCR2	1.34e-04	366	273	13	M41688
Coexpression	WANG_CLIM2_TARGETS_UP	KLF8 LRRC37A2 POGZ DBP SLC12A9 NFATC3 LDLRAD4 SEMA6B COL18A1 BRF1 MYB	1.35e-04	270	273	11	M10334
CoexpressionAtlas	facebase_RNAseq_e9.5_OlfPlac_2500_K3	SETD1B KCTD13 TSPOAP1 PPRC1 MCM2 RTN1 ZBED4 GLI2 GLIS2 TMEM59L UNKL ZC3H7B PRRC2A CCDC116 WNK2 WDR62 SLC27A3 HOMEZ BAHCC1 DOC2A B4GALNT4 MARCHF9 KIF21A DUSP4 FBRSL1 HUWE1 PHC1 NUAK2 ELL2 FAM222A RORC SCRIB RAI1 MYB	7.62e-06	1187	269	34	facebase_RNAseq_e9.5_OlfPlac_2500_K3
ToppCell	facs-Heart-RA-24m-Myeloid-macrophage\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP2F1 ITGA3 TMCO4 REEP6 SDC1 PLK3 CCDC116 FBXW9 DUSP4 FOSL1 SYT8 SYTL1	1.46e-09	181	274	12	c68d272eb41f81bd8ea4d0360733a2396bc87037
ToppCell	facs-Heart-RA-24m-Myeloid-macrophage\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP2F1 ITGA3 TMCO4 REEP6 SDC1 PLK3 CCDC116 FBXW9 DUSP4 FOSL1 SYT8 SYTL1	1.46e-09	181	274	12	5e5eb89f224ee48065a328ade030cbc4dcdcac12
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA3 NR4A1 KDM6B ZFP36L1 PRRC2A FOXJ1 ATN1 IL23A RASSF7 FOSL1 LTBP3 MTSS2	1.99e-09	186	274	12	bd1185592aedebccd1007dbf2dd2f549fcdf9f42
ToppCell	wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	KIAA0513 TSPOAP1 MED26 WNK2 ZFAT KIAA1549 NHSL1 KMT2D ELL2 MAP3K21 HCFC1	2.21e-08	185	274	11	636505a3d96f75d951ab42bcf8af6ae07abc732d
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA3 KDM6B ZFP36L1 PRRC2A FOXJ1 ATN1 IL23A RASSF7 FOSL1 LTBP3 MTSS2	2.75e-08	189	274	11	965e0e388251e7318f8b463816dc96ccb4658677
ToppCell	LA-14._Fibroblast_III\|LA / Chamber and Cluster_Paper	NR4A1 KDM6B GASK1B PTPRG ARID5B LAMA2 FOSL1 COL18A1 ELL2 ABCA6 VCAN	3.41e-08	193	274	11	7426c291bac59e539c427bcaae18abc7d397d44e
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PTPRG ZFP36L1 GLI2 CACNA2D1 SPATA6 TTC28 KALRN ABCA6 VCAN UNC5C MACF1	3.60e-08	194	274	11	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CETP PCDH12 DYSF PTPRG HECW2 ADGRF5 SEMA6B ROBO4 COL18A1 ADAMTS7 SP6	4.67e-08	199	274	11	463ba77dc4c85eebb343f29a42c7ac889b0497c9
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	STK36 SETD1B RC3H1 ARID1A NFATC3 SZT2 PTPN23 USF3 GIGYF2 MAP3K21	8.59e-08	166	274	10	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Trm_Th1/Th17\|lymph-node_spleen / Manually curated celltypes from each tissue	TNFRSF25 HLF NR4A1 KDM6B ZFP36L2 PLK3 DUSP4 DUSP8 IL23A RORC	2.74e-07	188	274	10	a20521198c6db17589535fb439533329582c9dd2
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	JPH4 APC2 RTN1 RUNDC3A PTPRN TMEM59L KIF21A TMEM151B PODXL2 PLPP4	2.74e-07	188	274	10	bd091503f580dedab40e0996273101285d24b586
ToppCell	control-immature_Neutrophil\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	KIAA0513 NR4A1 ARHGEF11 RTN1 GASK1B NFE2 IL17RA TNS3 IRGQ RORC	2.88e-07	189	274	10	bdfd120900ba58d5e54765f7b576e1f8cc2401bf
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PTPRG GLI2 CACNA2D1 SPATA6 TTC28 KALRN LAMA2 ABCA6 VCAN UNC5C	3.66e-07	194	274	10	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	wk_15-18-Epithelial-Distal_epithelial-type_II_pneumocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ITGA3 TMEM59L ADGRF5 SDC1 PRR36 PPP1R13B RASSF7 NHSL1 COL18A1 MAP3K21	3.84e-07	195	274	10	0e3aac1b1a1fd483f5fb9a394eb90c0e1ce63542
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ZFP36L1 CACNA2D1 SPATA6 KALRN LAMA2 ABCA6 VCAN UNC5C MACF1 PKN2	4.03e-07	196	274	10	1450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CETP PCDH12 DYSF GASK1B HECW2 ADGRF5 SEMA6B ROBO4 PPP1R13B LHX6	4.22e-07	197	274	10	f4834378d5d31560b4efe5dee0d5b5d11caeb10f
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ZFP36L1 ARID5B SPATA6 KALRN LAMA2 ABCA6 VCAN UNC5C MACF1 PKN2	4.22e-07	197	274	10	31a1852911bda38543916585fda34255fd62a134
ToppCell	PCW_13-14-Mesenchymal\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PTPRG ZFP36L1 GLI2 CACNA2D1 SPATA6 TTC28 LAMA2 ABCA6 VCAN UNC5C	4.22e-07	197	274	10	73a2085d2682d636726a5432d572ae2a3fbe1c3f
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	JPH4 APC2 RTN1 RUNDC3A PTPRN TMEM59L KIF21A DUSP4 TMEM151B PLPP4	4.22e-07	197	274	10	f7eaac1c321710a55e09ffb047a7db2baf7b7e28
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ZFP36L1 CACNA2D1 SPATA6 TTC28 KALRN LAMA2 ABCA6 VCAN UNC5C MACF1	4.42e-07	198	274	10	17dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ERBB4 RTN1 DMBT1 WNK2 DUSP4 NRG2 ITPRID1 ELL2 CRACDL UNC5C	4.85e-07	200	274	10	7c2d499af60654b7b28f172ac2c914ad49fb74b4
ToppCell	3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PPRC1 NR4A1 ZFP36L1 AJM1 CRAMP1 REV1 B4GALNT4 ARHGEF18 RAI1	1.19e-06	171	274	9	ea60d9e9df28ab991fbdb596784b44f6a9fc5827
ToppCell	normal_Lymph_Node-Myeloid_cells-pDCs\|Myeloid_cells / Location, Cell class and cell subclass	TSPYL2 CNTROB MED26 LDLRAD4 PODXL2 USF3 BRF1 RAI1 MYB	1.38e-06	174	274	9	2274648b80dd74f3c948a779bba3391095964c34
ToppCell	metastatic_Brain-Fibroblasts-Undetermined\|metastatic_Brain / Location, Cell class and cell subclass	MAP1A ST20-AS1 TSPOAP1 HLF HOXA2 MROH7 LGI4 UNC5C PLPP4	1.58e-06	177	274	9	54f39be5d90363cfd44dea1a96ae06d3143aa795
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-cycling_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CETP MCM2 PCDH12 DYSF ADGRF5 WDR62 ROBO4 PPP1R13B STIL	1.66e-06	178	274	9	462111b61f37338f97ac7dc6c7da1d4316b54445
ToppCell	frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ITPR2 ZFP36L1 ZFP36L2 KIR3DL1 TNS3 COL18A1 VCAN PLPP4	1.74e-06	133	274	8	63d2f096ae47d9b587acc6c5fbd346e5e58842b8
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PIDD1 MCM2 PCDH12 MOGS WDR62 FOXM1 SEMA6B LHX6 MDGA1	1.82e-06	180	274	9	40d4838a0ccb10d5e49266bc8a0037d27b75ccc2
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TNFRSF25 DYSF GASK1B MGAT1 SSH1 SEMA6B LHX6 FRY SYT8	2.38e-06	186	274	9	055cc23c4db9aad2d6c62e62c8e58bfe5047c6b1
ToppCell	droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK36 ARHGAP32 CCDC9B PCDH12 HOXA2 ADGRF5 ROBO4 SH3RF1 IL23A	2.38e-06	186	274	9	90d53c2597a9f3a2b39afba75adfc54f1ca0a4db
ToppCell	droplet-Liver-Hepatocytes-24m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK36 ARHGAP32 CCDC9B PCDH12 HOXA2 ADGRF5 ROBO4 SH3RF1 IL23A	2.38e-06	186	274	9	2cae34336f184f971f7c8684cc27c23a4e7369ed
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175\|Adult / Lineage, Cell type, age group and donor	CETP NR4A1 PCDH12 DYSF HECW2 CCDC116 ROBO4 TTC28 SP6	2.49e-06	187	274	9	f3548817f2fded5978137bb252cb628ac199e4f6
ToppCell	COPD-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	ITGA3 PCDH12 RTN1 HECW2 ADGRF5 ROBO4 KALRN ITPRID1 FRY	2.60e-06	188	274	9	1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51
ToppCell	3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-cycling_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CETP PCDH12 DYSF GASK1B HECW2 ADGRF5 ROBO4 PPP1R13B LHX6	2.60e-06	188	274	9	5d166d9e71632edd059ff0a9f66f8763f259d40a
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	LRRC37A3 RPRD1B CEP68 GLIS2 AMOTL2 TNS3 DLGAP4 COL18A1 VCAN	2.60e-06	188	274	9	14bc73cf79c79c9f208369fd8d498e5b26e0114d
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CETP PCDH12 DYSF GASK1B HECW2 ADGRF5 SEMA6B ROBO4 PPP1R13B	2.72e-06	189	274	9	9e58411e51019ca59e78d3e737d65d2bcbbea2be
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA3 NR4A1 KDM6B ITPR2 ZFP36L2 FOSL1 NHSL1 FRY TJAP1	2.72e-06	189	274	9	1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9
ToppCell	ILEUM\|World / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TSPYL2 NR4A1 KDM6B ZFP36L2 CRYBG1 SDC1 LDLRAD4 DUSP4 ELL2	2.84e-06	190	274	9	4395dbd18c14d491f5066a2ddac438a16b1fd7c3
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PIDD1 AGL PRRG4 GTPBP3 RASSF7 KANSL3 KMT2D MYB CXCR2	2.84e-06	190	274	9	3f0c7d130f66faea778fe567604edf1b4cdf85b3
ToppCell	5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor-Neuroblast\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ERBB4 APC2 RUNDC3A CACNA2D1 KIF21A TMEM151B PODXL2 LGI4 FAM222A	2.96e-06	191	274	9	c7b95a5f9185d533c08754ce2e4ce91533eb612e
ToppCell	facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_B_+_C\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP32 HLF MCM2 PTBP1 MOGS KIAA1549 LTBP3 MDGA1 MYB	3.09e-06	192	274	9	03dcd9405d3d76fc7455066ba5d83c09cd17072d
ToppCell	5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ERBB4 APC2 RUNDC3A CACNA2D1 KIF21A TMEM151B PODXL2 LGI4 FAM222A	3.09e-06	192	274	9	56f2388c9c4e19883ae5cff332c77f596ff744a8
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PIDD1 AGL PRRG4 GTPBP3 RASSF7 KANSL3 KMT2D MYB CXCR2	3.09e-06	192	274	9	c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN1C PCDH12 HECW2 ADGRF5 AMOTL2 ROBO4 TTC28 PCDHGA11 MTSS2	3.23e-06	193	274	9	826b8dd801298b3e0cd76232feae5a14026b8806
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN1C PCDH12 HECW2 ADGRF5 AMOTL2 ROBO4 TTC28 PCDHGA11 MTSS2	3.23e-06	193	274	9	87d3a577d37fb0cb4b6313c596310de452bc3872
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN1C PCDH12 HECW2 ADGRF5 AMOTL2 ROBO4 TTC28 PCDHGA11 MTSS2	3.23e-06	193	274	9	d485634c564b268e344b6a2863c26f6adaec9e38
ToppCell	10x5'v1-week_14-16-Endothelial-stroma-proliferating_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ITGA3 PCDH12 HECW2 ADGRF5 ROBO4 LHX6 SHROOM2 ADAMTS7 SP6	3.37e-06	194	274	9	8a4be91414a2e69dd410aa75791f16008204c9a1
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CETP PCDH12 DYSF HECW2 ADGRF5 SEMA6B ROBO4 PPP1R13B LHX6	3.51e-06	195	274	9	f65053811074a7f2ff0368f3a63b88e2a08da1a0
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PTPRG GLI2 CACNA2D1 TTC28 KALRN ABCA6 VCAN UNC5C MACF1	3.51e-06	195	274	9	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	JPH4 APC2 RTN1 RUNDC3A PTPRN TMEM59L KIF21A DUSP4 TMEM151B	3.51e-06	195	274	9	5a6a5048af638872700b76b7c71a8fa3fb8d3772
ToppCell	10x_3'_v3-blood_(10x_3'_v3)\|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	DYSF GASK1B RUNDC3A NFE2 IL17RA TREML1 NUP214 VCAN CXCR2	3.82e-06	197	274	9	2d3547107c88c7443fc6425742694e13368a71f5
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LRRC37A3 LRRC37A DNAH6 FOXJ1 DOC2A FOXM1 STIL DNAH1 MYB	3.82e-06	197	274	9	6e4a411ef823ce9e16f420e185e21fa19d13af34
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	APC2 RTN1 RUNDC3A TMEM59L CACNA2D1 KIF21A DUSP4 PODXL2 PLPP4	3.82e-06	197	274	9	b9478212f14b7888e3abac02995177974ac3bd17
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	PTPRG GLI2 CACNA2D1 TTC28 KALRN LAMA2 ABCA6 VCAN UNC5C	3.82e-06	197	274	9	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	JPH4 APC2 RTN1 RUNDC3A TMEM59L KIF21A DUSP4 TMEM151B PLPP4	3.82e-06	197	274	9	27c044833e471a312a572e0b1c83e4bc8a36e896
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	APC2 RTN1 RUNDC3A TMEM59L CACNA2D1 KIF21A TMEM151B PODXL2 PLPP4	3.82e-06	197	274	9	c220102fadbb7ba385a61704a144e0b814cb5c46
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	JPH4 APC2 RTN1 RUNDC3A TMEM59L KIF21A DUSP4 TMEM151B PLPP4	3.98e-06	198	274	9	85881637641d8996be2edc65c4bceff0433135e7
ToppCell	severe-HLA-DR+_CD83+_Monocyte\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	KDM6B RNF217 RTN1 ZFP36L1 MUC17 IL17RA PLK3 TNS3 VCAN	3.98e-06	198	274	9	a77f3440d7fb6a50066abc7e9ad59e83798ef13d
ToppCell	LPS_only-Epithelial_airway-airway_epithelial-Ciliated\|LPS_only / Treatment groups by lineage, cell group, cell type	STK36 RTN1 MYO15B SLC12A9 DNAH6 FOXJ1 DNAH1 C9orf50 ARHGAP33	3.98e-06	198	274	9	6d90b541fde357fbb40f8f7d4e8628a48b679718
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PTPRG GLI2 CACNA2D1 TTC28 KALRN LAMA2 ABCA6 VCAN UNC5C	3.98e-06	198	274	9	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CETP PCDH12 DYSF HECW2 ADGRF5 SEMA6B ROBO4 PPP1R13B LHX6	3.98e-06	198	274	9	96d46e73f968391000ecd14c787efb93c79f96ec
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CETP PCDH12 DYSF HECW2 ADGRF5 SEMA6B ROBO4 COL18A1 FRY	4.14e-06	199	274	9	0602e2b2aa56d106da63bd342a38bef437b4d496
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-SELL+_CD4_T\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TNFRSF25 TSPYL2 NR4A1 PLK3 ARHGAP9 IL23A LAT ARHGEF1 SYTL1	4.14e-06	199	274	9	b01328a80db5bb088c44564cea0f6729b1a9805b
ToppCell	distal-Endothelial-Capillary_Aerocyte-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ITGA3 PCDH12 ZFP36L1 HECW2 ADGRF5 ROBO4 KALRN NUAK2 FRY	4.14e-06	199	274	9	9021f4be004efd51bb3658e5bbff53589356b3df
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP32 ERBB4 WNK2 SH3RF1 MUC16 PPP1R13B TACC2 CRACDL SYTL1	4.32e-06	200	274	9	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	distal-2-Endothelial-Capillary_Intermediate_1\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CDKN1C ITGA3 PCDH12 HECW2 ADGRF5 ROBO4 NUAK2 FRY CRACDL	4.32e-06	200	274	9	7a99f28670ffb8ece7873d8a9bcd2a3936d0255d
ToppCell	distal-Endothelial-Capillary_Intermediate_1-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CDKN1C ITGA3 PCDH12 HECW2 ADGRF5 ROBO4 NUAK2 FRY CRACDL	4.32e-06	200	274	9	43bc48413b100a06f8edd9acd812296788fcbf5b
ToppCell	distal-Endothelial-Capillary_Intermediate_1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CDKN1C ITGA3 PCDH12 HECW2 ADGRF5 ROBO4 NUAK2 FRY CRACDL	4.32e-06	200	274	9	4d6714d48738cdee7d535923f6dd2431e5304741
ToppCell	NS-moderate-d_07-13-Epithelial-FOXN4+\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MAP1A DNAH6 WDR62 FAM149A DOC2A SPATA6 STIL MYB	5.97e-06	157	274	8	410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBED4 SLC27A3 HOMEZ KIAA1549 VCAN PLPP4 ZBTB3 ARMH4	8.22e-06	164	274	8	0853e75b60b2a78257b660910c3ee15b09c5f5b0
ToppCell	5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HGFAC RUNDC3A PTPRN DNAH6 CACNA2D1 SP6 PAX4 NPAS4	8.59e-06	165	274	8	4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496
ToppCell	COVID-19_Mild-PLT_0\|COVID-19_Mild / Disease Group and Platelet Clusters	CYP2F1 NUFIP1 SSH1 AGL ATN1 USF3 MACF1 ARHGAP33	8.59e-06	165	274	8	083a14d3b0162cee4e79f7398b8fb739582b39ff
ToppCell	ICU-SEP-Lymphocyte-T_NK-dnT\|ICU-SEP / Disease, Lineage and Cell Type	LRRC37A2 UNKL BAHCC1 KALRN IL23A CRACDL MDGA1 MYB	8.98e-06	166	274	8	96d92316cee20b722fe782db9dafcceb8f2c220b
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Trf.Ctps_(Ctps)\|Striatum / BrainAtlas - Mouse McCarroll V32	GGT6 PKD1L1 SSPOP IL23A CACNA2D4 CXCR2	9.25e-06	79	274	6	239d34f40c3a96186231f3aabd41c4988af3f372
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf\|Striatum / BrainAtlas - Mouse McCarroll V32	GGT6 PKD1L1 SSPOP IL23A CACNA2D4 CXCR2	9.25e-06	79	274	6	a60fcbb278ba629af922c53faf58e4d96c537b15
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFRSF25 PLEKHG5 ZFP36L1 UNKL PLK3 B4GALNT4 GSDMA RORC	9.38e-06	167	274	8	713899690e4acd9d259645e363c26983d6ef3022
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-BM_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFRSF25 PLEKHG5 ZFP36L1 UNKL PLK3 B4GALNT4 GSDMA RORC	9.38e-06	167	274	8	d30b96c39da3dd02500443877a4eb3500e26802c
ToppCell	E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GATA1 ZFP36L2 NFE2 ARHGEF18 ARHGAP9 LAT SYTL1 CXCR2	1.02e-05	169	274	8	b23d0aaa2da333b9c69a7aee862d5a5d2a1bf79b
ToppCell	E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GATA1 ZFP36L2 NFE2 ARHGEF18 ARHGAP9 LAT SYTL1 CXCR2	1.02e-05	169	274	8	83d1bcf33872b01ea9614f608a3e4ab30df25c7e
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_Tfh\|T/NK_cells / Location, Cell class and cell subclass	TNFRSF25 CENPN ARID5B REV1 ARHGEF5 DUSP4 FBRSL1 C2CD3	1.02e-05	169	274	8	625788d86f0ceebcf2653a251db1f1a9f9746d29
ToppCell	wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor-MUC5AC+ASCL1+_intermediate_\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	GGT6 TMCO4 UTF1 FOXJ1 SYT8 CRACDL SP6 SYTL1	1.07e-05	170	274	8	d6e244725b21592c6056b9c443aac090f1eae836
ToppCell	facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1A CNTROB KALRN PODXL2 TG UNC5C RORC ZBTB3	1.11e-05	171	274	8	b54d9d6b03c9c6f28a71cf2ed2bfa9a335bba949
ToppCell	facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1A CNTROB KALRN PODXL2 TG UNC5C RORC ZBTB3	1.11e-05	171	274	8	9d825a2e799421af4f2cf4f4dc8e239b5d00476d
ToppCell	368C-Myeloid-Mast_cell-\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	MAP1A TSPYL2 GATA1 NR4A1 CACNA2D1 KIAA1549 LAT ADAMTS7	1.21e-05	173	274	8	fb87ea74bf70aa83b458edf728c81857c8b8eb96
ToppCell	facs-Large_Intestine-Distal-24m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN1C MAP1A WNK2 KALRN ITPRID1 ADAMTS7 GSDMA CXCR2	1.21e-05	173	274	8	f0eb48c1283bdde313bb75f6ffc0d2626922d24b
ToppCell	368C-Myeloid-Mast_cell\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	MAP1A TSPYL2 GATA1 NR4A1 CACNA2D1 KIAA1549 LAT ADAMTS7	1.21e-05	173	274	8	8cffb4a37d30b6626188309b868ac4a62e91262f
ToppCell	10x5'-GI_small-bowel-Mast-Mast_cells\|GI_small-bowel / Manually curated celltypes from each tissue	DOK3 GATA1 NFE2 MROH7 CACNA2D1 KIAA1549 ADAMTS7 ARMH4	1.26e-05	174	274	8	05525bf0a2bde2be4f7c147b17a24530ce8819e0
ToppCell	10x5'-GI_small-bowel-Mast\|GI_small-bowel / Manually curated celltypes from each tissue	DOK3 GATA1 NFE2 MROH7 CACNA2D1 KIAA1549 ADAMTS7 ARMH4	1.26e-05	174	274	8	e94c980b25edfd0e8598c416828801fcc00e8ead
ToppCell	metastatic_Brain-T/NK_cells-Exhausted_Tfh\|metastatic_Brain / Location, Cell class and cell subclass	TNFRSF25 CYP2F1 ARID5B GTPBP3 KIR3DL1 DUSP4 LAT PCIF1	1.32e-05	175	274	8	b732c6a423c28856211002107d8c611dcfb6f265
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ERBB4 JPH4 APC2 RTN1 GPR179 TMEM59L KIF21A PLPP4	1.37e-05	176	274	8	116741fef5895ca85057d2d31eca9eba5764ab44
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-B_cells-CLP\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GATA1 NFE2 LDLRAD4 ARHGAP9 LAT RORC SYTL1 MYB	1.37e-05	176	274	8	f163cc6d632112aad35a0a9217c6c99fbdd1386e
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ERBB4 JPH4 APC2 RTN1 GPR179 TMEM59L KIF21A PLPP4	1.37e-05	176	274	8	5b707f58d164ee7a6a527dd5d053472ce9a631c1
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	LRRC37A3 RPRD1B NUFIP1 GLIS2 AMOTL2 TNS3 DLGAP4 VCAN	1.49e-05	178	274	8	edc76b8f15056ec1c9a1c61a048b6331a92592d6
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD4-Trm_Th1/Th17\|GI_large-bowel / Manually curated celltypes from each tissue	NR4A1 GASK1B ZFP36L1 TSNARE1 FRY LAT UNC5C RORC	1.55e-05	179	274	8	6359f30005b17dc5b5c4c8f3a6a38c87ccfe4ee9
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CETP PCDH12 DYSF CEP68 HECW2 ROBO4 LHX6 SP6	1.62e-05	180	274	8	97e0dcb7cfbba60a782824c5e23995058609fcd4
ToppCell	3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ERBB4 CCDC9B GASK1B PRRG4 TNS3 LAMA2 LGI4 COL18A1	1.62e-05	180	274	8	38490017dd590e3fcfa7e88d8d15235d55f90cf1
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	JPH4 APC2 RTN1 RUNDC3A TMEM59L KIF21A DUSP4 PLPP4	1.62e-05	180	274	8	368ff7fcfd21ad248f96a83a8b191040ba7d8670
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DYSF RNF217 AJM1 WDR62 FOXJ1 TMEM151B IL23A SYT8	1.68e-05	181	274	8	7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57
ToppCell	5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NR4A1 KDM6B PTPRG ZFP36L1 LAMA2 FOSL1 ELL2 VCAN	1.68e-05	181	274	8	ab66a89f316b935d9ba1277426d976b1e9e39757
ToppCell	COVID-19-Endothelial_cells-Capillary_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ITGA3 RTN1 HECW2 ADGRF5 ROBO4 KALRN ITPRID1 SHROOM2	1.68e-05	181	274	8	c5f9c92af1384d9089c65afdf41c6feb8345a3ae
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	APC2 RTN1 GPR179 RUNDC3A TMEM59L CACNA2D1 KIF21A PLPP4	1.82e-05	183	274	8	7e2bac8b005155888ff4b41ef2e1d975dc17abc7
Drug	Nocodazole [31430-18-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A	KCTD13 ZFP36L2 DMBT1 ZC3H7B PLK3 UTF1 WDR62 PRR36 DUSP4 NUAK2 FOSL1 TJAP1 HCFC1 CXCR2	5.71e-08	186	272	14	6793_UP
Drug	Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HT_HG-U133A	CDKN1C TNFRSF25 KCTD13 MAP1A HLF ARID1A ZBED4 NFATC3 BAHCC1 NUP214 ARHGEF1 VCAN ARHGAP33 MTSS2	9.65e-08	194	272	14	6660_DN
Drug	irinotecan HCl; Up 200; 100uM; MCF7; HT_HG-U133A	TNFRSF25 KCTD13 MAP1A TSPYL2 PIDD1 KDM6B SDC1 PLK3 DOC2A MKNK2 LHX6 FOSL1 LAT	3.79e-07	185	272	13	7498_UP
Drug	Piperine [94-62-2]; Down 200; 14uM; PC3; HT_HG-U133A	CDKN1C MAP1A SRCAP ITPR2 RUNDC3A ZFP36L1 ZFP36L2 ATN1 DLGAP4 NUP214 KANSL3 VCAN MTSS2	5.46e-07	191	272	13	4247_DN
Drug	Indoprofen [31842-01-0]; Down 200; 14.2uM; PC3; HT_HG-U133A	KDM6B CEP68 RUNDC3A NF2 ZFP36L1 ZFP36L2 ATN1 NRG2 KANSL3 COL18A1 VCAN HCFC1 CXCR2	6.52e-07	194	272	13	4249_DN
Drug	Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; PC3; HT_HG-U133A	CDKN1C PIDD1 KDM6B RUNDC3A ZFP36L2 ATN1 POLG DLGAP4 TUT1 KANSL3 VCAN CXCR2 MTSS2	7.32e-07	196	272	13	4227_DN
Drug	Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; PC3; HT_HG-U133A	CDKN1C KCTD13 DBP NR4A1 PCDH12 ZBED4 ZFP36L1 ZFP36L2 ATN1 NUP214 KANSL3 VCAN HCFC1	7.76e-07	197	272	13	4207_DN
Drug	Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A	TNFRSF25 PIDD1 HOXA2 ZFP36L1 NFATC3 ZC3H7B PLK3 PRR36 KALRN SZT2 LHX6 BRF1 ARHGAP33	7.76e-07	197	272	13	2328_UP
Drug	Reserpine [50-55-5]; Down 200; 6.6uM; PC3; HT_HG-U133A	CDKN1C TNFRSF25 KCTD13 PCDH12 KDM6B ITPR2 CENPT ATN1 DUSP8 TUT1 KANSL3 VCAN MTSS2	8.21e-07	198	272	13	4203_DN
Drug	Ivermectin [70288-86-7]; Up 200; 4.6uM; MCF7; HT_HG-U133A	NR4A1 SRCAP NF2 ZFP36L1 PPP1R37 PRRG4 PLK3 SEMA6B DUSP4 NUP214 NUAK2 MTSS2	1.65e-06	178	272	12	2213_UP
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A	SETD1B TNIP1 ARID1A NFE2 DENND4B PRRG4 IL23A MICALL1 VCAN TNFRSF1A HCFC1 MYB	1.76e-06	179	272	12	1175_DN
Drug	Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; PC3; HT_HG-U133A	RUNDC3A NF2 ZFP36L1 ZFP36L2 ATN1 DLGAP4 TUT1 NUP214 KANSL3 VCAN HCFC1 CXCR2	3.84e-06	193	272	12	4226_DN
Drug	PHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A	RNF40 POGZ NR4A1 ARHGEF11 ZFP36L2 PLK3 CENPT SZT2 DLGAP4 SHROOM2 BRF1 HCFC1	4.05e-06	194	272	12	4559_DN
Drug	Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; PC3; HT_HG-U133A	MAP1A CEP68 RUNDC3A ZFP36L1 ZFP36L2 ATN1 DLGAP4 NRG2 KANSL3 VCAN CXCR2 MTSS2	4.05e-06	194	272	12	4248_DN
Drug	Thalidomide [50-35-1]; Up 200; 15.4uM; MCF7; HT_HG-U133A	ERBB4 DOK3 NR4A1 GLI2 PPP1R37 KANSL3 KMT2D BRF1 TJAP1 PAX4 RAI1 MTSS2	4.28e-06	195	272	12	5990_UP
Drug	Hesperetin [520-33-2]; Up 200; 13.2uM; MCF7; HT_HG-U133A	KDM6B SRCAP ARID1A NF2 ZFP36L1 ZFP36L2 ZC3H7B PRRC2A BAHCC1 DLGAP4 BRF1 MAP1S	4.51e-06	196	272	12	5350_UP
Drug	Indapamide [26807-65-8]; Down 200; 10.6uM; HL60; HT_HG-U133A	KCTD13 KDM6B SLC12A9 ZFP36L2 NFATC3 UNKL IRGQ RASSF7 PCIF1 MACF1 HCFC1 CXCR2	4.51e-06	196	272	12	2361_DN
Drug	Chlorzoxazone [95-25-0]; Up 200; 23.6uM; HL60; HG-U133A	MAP1A DMBT1 ZC3H7B WDR62 ROBO4 ATN1 LAMA2 PPP1R13B TUT1 NUP214 COL18A1 TJAP1	4.51e-06	196	272	12	1416_UP
Drug	Chloroquine diphosphate [50-63-5]; Up 200; 7.8uM; PC3; HT_HG-U133A	TNFRSF25 PIDD1 NR4A1 CEP68 GLI2 ZC3H7B TTC28 SZT2 PPP1R13B TUT1 NUAK2 TJAP1	4.51e-06	196	272	12	7251_UP
Drug	Azathioprine [446-86-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A	MAP1A BAHCC1 SZT2 NRG2 LHX6 TG ARSA ARHGEF1 TJAP1 PAX4 HCFC1 ARHGAP33	4.75e-06	197	272	12	1528_UP
Drug	Sulfabenzamide [127-71-9]; Up 200; 14.4uM; MCF7; HT_HG-U133A	CDKN1C HLF NR4A1 SRCAP NF2 LAMA2 AIRE NUP214 HUWE1 GPATCH3 RORC ARHGAP33	4.75e-06	197	272	12	4979_UP
Drug	prochlorperazine dimaleate salt; Down 200; 10uM; PC3; HT_HG-U133A	ARHGAP32 PPRC1 PIDD1 KDM6B ZBED4 MOGS DENND4B IL17RA PRRC2A SHROOM2 PDCD11 MAST3	4.75e-06	197	272	12	1215_DN
Drug	Minoxidil [38304-91-5]; Down 200; 19.2uM; MCF7; HT_HG-U133A	PIDD1 CEP68 NF2 ZFP36L1 ATN1 TTC28 PRR36 FOSL1 BRF1 MAP1S PDCD11 ARHGAP33	5.00e-06	198	272	12	4800_DN
Drug	nordihydroguaiaretic acid; Down 200; 1uM; ssMCF7; HG-U133A	GAPVD1 NR4A1 PCDH12 ARHGEF11 DYSF CEP68 PRRG4 TNS3 TTC28 ARSA ZNF277 RORC	5.00e-06	198	272	12	415_DN
Drug	Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	MAP1A KIAA0513 SRCAP ZFP36L1 IL17RA PRRC2A BAHCC1 CENPT TUT1 COL18A1 PCSK7 HCFC1	5.00e-06	198	272	12	7035_UP
Drug	clozapine; Up 200; 10uM; MCF7; HT_HG-U133A_EA	TSPYL2 SRCAP ARHGEF11 ZFP36L2 NFATC3 PLK3 CENPT RPS6KA4 TTC28 PODXL2 NUP214 ARHGAP33	5.27e-06	199	272	12	1009_UP
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	SETD1B PPRC1 ARID1A ZFP36L1 ZFP36L2 DENND4B UNKL AMOTL2 TNS3 TACC2 MYB	7.47e-06	172	272	11	1072_DN
Drug	SAHA; Down 200; 10uM; HL60; HT_HG-U133A	SETD1B PPRC1 ARID1A ZFP36L2 NFE2 DENND4B PRRG4 MICALL1 VCAN TNFRSF1A MYB	8.80e-06	175	272	11	1161_DN
Drug	D and C Red No. 9	CETP GATA1 MOGS AGL	9.15e-06	12	272	4	CID009570201
Drug	CP-319743 [172078-87-4]; Up 200; 10uM; PC3; HT_HG-U133A	CDKN1C TNFRSF25 KCTD13 NR4A1 SRCAP ARHGEF11 NF2 NFATC3 SZT2 MICALL1 ZBTB3	1.81e-05	189	272	11	7537_UP
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A	NR4A1 PTBP1 SRCAP ZFP36L1 ZFP36L2 BAHCC1 ATN1 POM121L2 HUWE1 MICALL1 HCFC1	1.91e-05	190	272	11	4340_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	KCTD13 CEP68 MOGS NF2 ZFP36L1 ZFP36L2 BAHCC1 CENPT PPP1R13B SHROOM2 MICALL1	1.91e-05	190	272	11	5586_DN
Drug	Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; PC3; HT_HG-U133A	CDKN1C TNFRSF25 DBP PCDH12 KDM6B ATN1 POLG TUT1 KANSL3 HCFC1 MTSS2	2.21e-05	193	272	11	4186_DN
Drug	Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; PC3; HT_HG-U133A	CDKN1C PCDH12 KDM6B SRCAP ZFP36L2 PLK3 ATN1 NRG2 KANSL3 ZNF277 MTSS2	2.21e-05	193	272	11	4202_DN
Drug	Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; PC3; HT_HG-U133A	TNFRSF25 KDM6B RUNDC3A NF2 ZFP36L2 ATN1 TUT1 KANSL3 COL18A1 CXCR2 MTSS2	2.21e-05	193	272	11	4241_DN
Drug	Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A	ARID1A ARHGEF11 DYSF NF2 ZFP36L2 NFATC3 WDR62 BAHCC1 DLGAP4 TJAP1 ZBTB3	2.31e-05	194	272	11	4738_DN
Drug	0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A	KCTD13 PIDD1 SRCAP ZFP36L2 NFATC3 ZC3H7B TNS3 PRR36 DUSP4 HUWE1 FOSL1	2.31e-05	194	272	11	3969_DN
Drug	Equilin [474-86-2]; Down 200; 15uM; MCF7; HT_HG-U133A	TNFRSF25 PIDD1 SRCAP ARID1A ITPR2 ZFP36L1 ZFP36L2 ZC3H7B SZT2 NRG2 BRF1	2.31e-05	194	272	11	5620_DN
Drug	Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A	HGFAC TSPYL2 SRCAP ZC3H7B PRR36 SZT2 DUSP4 NRG2 HCFC1 MAST3 MTSS2	2.31e-05	194	272	11	6835_UP
Drug	2-propylpentanoic acid; Down 200; 500uM; HL60; HT_HG-U133A	TSPYL2 NF2 ZC3H7B COQ6 TUT1 MICALL1 LAT PCIF1 ANKRD11 TJAP1 ZBTB3	2.31e-05	194	272	11	6199_DN
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; PC3; HT_HG-U133A	TNFRSF25 KCTD13 MAP1A KDM6B CEP68 ZFP36L1 ZFP36L2 ATN1 KANSL3 PCIF1 MTSS2	2.31e-05	194	272	11	4242_DN
Drug	clofibrate; Up 200; 150uM; MCF7; HG-U133A	MAP1A HLF ARID1A ZFP36L1 PPP1R37 ATN1 KALRN POLG AIRE HUWE1 MICALL1	2.31e-05	194	272	11	263_UP
Drug	Berberine chloride [633-65-8]; Up 200; 10.8uM; MCF7; HT_HG-U133A	KCTD13 NR4A1 DYSF ITPR2 NF2 ZFP36L2 PLK3 SZT2 KMT2D BRF1 TJAP1	2.43e-05	195	272	11	2770_UP
Drug	Acacetin [480-44-4]; Down 200; 14uM; PC3; HT_HG-U133A	CDKN1C SRCAP ZFP36L1 ZFP36L2 ARID5B PRRC2A CENPT ATN1 BRF1 TJAP1 ARHGAP33	2.43e-05	195	272	11	4324_DN
Drug	trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	SH3GLB2 KDM6B ARHGEF11 ITPR2 PTPRG SLC12A9 RPS6KA4 PRR36 POLG NUP214 MAP1S	2.43e-05	195	272	11	1649_DN
Drug	Sulfisoxazole [127-69-5]; Up 200; 15uM; MCF7; HT_HG-U133A	CDKN1C MAP1A NR4A1 ZFP36L2 WDR62 DLGAP4 RAPGEF1 HUWE1 LAT ZNF277 CXCR2	2.54e-05	196	272	11	5622_UP
Drug	Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; PC3; HT_HG-U133A	CEP68 NF2 SLC12A9 ZFP36L2 DENND4B ZC3H7B ATN1 DUSP8 THAP7 VCAN CEP131	2.54e-05	196	272	11	6619_DN
Drug	Azathioprine [446-86-6]; Down 200; 14.4uM; PC3; HT_HG-U133A	CDKN1C KIAA0513 PCDH12 NF2 ZFP36L2 ZC3H7B LDLRAD4 ATN1 NRG2 NUP214 VCAN	2.54e-05	196	272	11	4667_DN
Drug	Pentamidine isethionate [140-64-7]; Down 200; 6.8uM; MCF7; HT_HG-U133A	PIDD1 DBP SRCAP SLC12A9 ZC3H7B RPS6KA4 POLG LHX6 NUAK2 MICALL1 ZNF277	2.54e-05	196	272	11	2834_DN
Drug	Methiazole; Down 200; 15uM; MCF7; HT_HG-U133A	TNFRSF25 SRCAP ITPR2 NF2 ZFP36L2 PLK3 ATN1 MICALL1 BRF1 ZNF277 MAST3	2.54e-05	196	272	11	3878_DN
Drug	Pipenzolate bromide [125-51-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A	TNFRSF25 HLF CAMTA2 NR4A1 RUNDC3A ZC3H7B DUSP8 POM121L2 LAT ZNF277 ARHGAP33	2.54e-05	196	272	11	6821_UP
Drug	Econazole nitrate [24169-02-6]; Down 200; 9uM; HL60; HT_HG-U133A	TSPOAP1 NR4A1 PCDH12 SRCAP ARHGEF11 NF2 ZFP36L2 NFE2 PRRC2A IRGQ CXCR2	2.54e-05	196	272	11	2396_DN
Drug	Methotrimeprazine maleat salt [7104-38-3]; Down 200; 9uM; MCF7; HT_HG-U133A	TNFRSF25 PIDD1 SRCAP ZFP36L2 ZC3H7B DOC2A TTC28 IL23A BRF1 MAP1S HCFC1	2.54e-05	196	272	11	4723_DN
Drug	Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A	KCTD13 MAP1A ATN1 TTC28 PRR36 TUT1 HUWE1 LHX6 KANSL3 BRF1 MAST3	2.67e-05	197	272	11	6241_UP
Drug	N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; PC3; HT_HG-U133A	CDKN1C PIDD1 PCDH12 KDM6B NF2 ZFP36L2 ZC3H7B LDLRAD4 NUP214 ZBTB3 MAST3	2.67e-05	197	272	11	6732_DN
Drug	Ifenprodil tartrate [23210-58-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A	SRCAP ZFP36L2 DMBT1 FAM149A DLGAP4 LAMA2 MUC16 NUP214 GPATCH3 ARHGAP33 MTSS2	2.67e-05	197	272	11	5463_UP
Drug	Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; PC3; HT_HG-U133A	CDKN1C ZFYVE16 TSPYL2 CAMTA2 ARID1A UNKL PRRC2A DUSP8 THAP7 BRF1 TJAP1	2.67e-05	197	272	11	2059_DN
Drug	2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; MCF7; HT_HG-U133A	PIDD1 ARID1A ZFP36L2 IL17RA WDR62 POLG DUSP8 ARHGEF1 ARHGAP33 MAST3 MYB	2.79e-05	198	272	11	5422_UP
Drug	Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; HL60; HT_HG-U133A	KDM6B SRCAP DYSF NF2 ZFP36L2 PRRC2A RASSF7 NUAK2 GPATCH3 ZNF277 PCIF1	2.79e-05	198	272	11	2392_DN
Drug	0173570-0000 [211245-44-2]; Up 200; 1uM; PC3; HT_HG-U133A	CDKN1C TNFRSF25 NF2 ZFP36L2 DMBT1 ATN1 POLG DLGAP4 NUP214 TJAP1 CEP131	2.79e-05	198	272	11	7391_UP
Drug	haloperidol; Down 200; 10uM; PC3; HT_HG-U133A	TNFRSF25 NR4A1 HOXA2 DENND4B IL17RA DMBT1 ZC3H7B RPS6KA4 POLG VCAN HCFC1	2.79e-05	198	272	11	1244_DN
Drug	Naproxen [22204-53-1]; Down 200; 17.4uM; HL60; HT_HG-U133A	SRCAP ARHGEF11 CEP68 MOGS NFATC3 UNKL ZC3H7B LDLRAD4 RPS6KA4 DUSP4 MICALL1	2.79e-05	198	272	11	1869_DN
Drug	trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HG-U133A	KCTD13 NR4A1 SRCAP CEP68 IL17RA RPS6KA4 TMEM151B NUP214 BRF1 PCSK7 MAST3	2.79e-05	198	272	11	421_DN
Drug	U-62066 [87151-85-7]; Down 200; 1uM; MCF7; HT_HG-U133A	TNFRSF25 NR4A1 SRCAP ARID1A ZC3H7B WDR62 ATN1 TTC28 MICALL1 ZNF277 MAST3	2.79e-05	198	272	11	3901_DN
Drug	Nomegestrol acetate [58652-20-3]; Down 200; 10.8uM; PC3; HT_HG-U133A	MAP1A SH3GLB2 ZBED4 NF2 SLC12A9 ZC3H7B LDLRAD4 DUSP8 ZNF277 VCAN PCSK7	2.79e-05	198	272	11	6362_DN
Drug	Metrizamide [31112-62-6]; Down 200; 5uM; HL60; HT_HG-U133A	PIDD1 CAMTA2 ARHGEF11 DYSF ZFP36L2 PRRC2A RPS6KA4 DUSP4 FOSL1 TJAP1 MAST3	2.93e-05	199	272	11	1318_DN
Drug	Karakoline [39089-30-0]; Down 200; 10.6uM; PC3; HT_HG-U133A	CDKN1C MAP1A PIDD1 SRCAP ZFP36L1 UNKL DMBT1 WDR62 ATN1 LAT MAST3	2.93e-05	199	272	11	4297_DN
Drug	Sulfanilamide [63-74-1]; Up 200; 23.2uM; MCF7; HT_HG-U133A	CEP68 NF2 PRRG4 LDLRAD4 WDR62 PRR36 ARHGEF18 NUAK2 LAT ARHGEF1 CXCR2	2.93e-05	199	272	11	3449_UP
Drug	Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; PC3; HT_HG-U133A	TNFRSF25 DBP KDM6B RUNDC3A ZFP36L1 ZFP36L2 ZC3H7B ATN1 IL23A HCFC1 MTSS2	2.93e-05	199	272	11	4228_DN
Drug	Myosmine [532-12-7]; Up 200; 27.4uM; MCF7; HT_HG-U133A	TNFRSF25 NR4A1 ITPR2 BAHCC1 ATN1 LAMA2 POM121L2 HUWE1 KANSL3 LAT MYB	3.06e-05	200	272	11	4759_UP
Drug	celecoxib; Up 200; 10uM; MCF7; HG-U133A	DOK3 GATA1 DYSF ITPR2 TMEM59L PLK3 RPS6KA4 NUP214 HUWE1 LAT ARHGAP33	3.06e-05	200	272	11	252_UP
Drug	delphinidin-3-glucoside	FOXM1 RAPGEF1 MYB	3.28e-05	6	272	3	CID000165558
Drug	sn-3-dihexadecylphosphatidylcholine	STK36 SDC1 PCSK7	3.28e-05	6	272	3	CID000118294
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	SRCAP ARID1A ZFP36L1 ZFP36L2 TNS3 DUSP4 FOSL1 MICALL1 TNFRSF1A MYB	3.60e-05	168	272	10	3868_DN
Drug	felodipine; Up 200; 10uM; MCF7; HT_HG-U133A_EA	TSPYL2 NR4A1 KDM6B SRCAP ZFP36L1 ZC3H7B PRR36 DUSP4 NUAK2 FOSL1	3.98e-05	170	272	10	965_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	SETD1B PPRC1 POGZ ARID1A ZFP36L2 UNKL PRRG4 MICALL1 HCFC1 MYB	3.98e-05	170	272	10	5260_DN
Drug	0179445-0000 [211246-22-9]; Up 200; 10uM; MCF7; HT_HG-U133A	SRCAP GASK1B NFATC3 WDR62 CACNA2D1 FOSL1 BRF1 ADAMTS7 VCAN MYB	6.16e-05	179	272	10	3630_UP
Drug	Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; PC3; HT_HG-U133A	ARHGAP32 SETD1B PPRC1 ARID1A ZFP36L1 ZFP36L2 ARID5B AMOTL2 DUSP4 FOSL1	7.76e-05	184	272	10	4610_DN
Drug	Felodipine [72509-76-3]; Up 200; 10.4uM; MCF7; HT_HG-U133A	NR4A1 SRCAP NF2 WDR62 DUSP8 PODXL2 NUAK2 FOSL1 HCFC1 ARHGAP33	8.88e-05	187	272	10	5294_UP
Drug	genistein; Down 200; 10uM; HL60; HT_HG-U133A	KCTD13 NFATC3 NFE2 PRRG4 RPS6KA4 MAP1S PDCD11 HCFC1 MAST3 MYB	9.28e-05	188	272	10	1176_DN
Drug	Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; HL60; HT_HG-U133A	POGZ KDM6B ITPR2 CEP68 NFATC3 UNKL PRRG4 ZC3H7B POLG C2CD3	9.28e-05	188	272	10	1865_DN
Drug	ionomycin calcium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA	CDKN1C MAP1A TSPYL2 CAMTA2 PCDH12 LDLRAD4 DUSP4 NRG2 NUP214 HUWE1	9.70e-05	189	272	10	882_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	ARHGAP32 KCTD13 CEP68 ZFP36L1 ZFP36L2 DUSP8 IRGQ MICALL1 MAST3 MYB	9.70e-05	189	272	10	1651_DN
Drug	celecoxib; Up 200; 10uM; MCF7; HT_HG-U133A_EA	CDKN1C CAMTA2 NR4A1 PCDH12 TTC28 LHX6 NUAK2 FOSL1 KANSL3 PAX4	9.70e-05	189	272	10	922_UP
Drug	Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A	TNFRSF25 ARHGEF11 ZFP36L2 PRRC2A SDC1 BAHCC1 ATN1 COL18A1 HCFC1 MAST3	1.15e-04	193	272	10	3262_UP
Drug	Fenbufen [36330-85-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A	TNFRSF25 NR4A1 RUNDC3A WDR62 FAM149A ATN1 POM121L2 KANSL3 ZNF277 MAST3	1.15e-04	193	272	10	4743_UP
Drug	Promethazine hydrochloride [58-33-3]; Up 200; 12.4uM; PC3; HT_HG-U133A	TNFRSF25 TNIP1 ZFP36L2 AMOTL2 CACNA2D1 IL23A NUAK2 VCAN ARHGAP33 MTSS2	1.15e-04	193	272	10	6717_UP
Drug	Vitamin K2 [11032-49-8]; Up 200; 9uM; MCF7; HT_HG-U133A	SETD1B ARID1A ITPR2 NF2 FAM135A LDLRAD4 FAM149A DUSP4 LAT RORC	1.15e-04	193	272	10	3880_UP
Drug	Carcinine [56897-53-1]; Down 200; 22uM; PC3; HT_HG-U133A	PIDD1 DBP CEP68 RUNDC3A ZFP36L1 ZFP36L2 NRG2 NUP214 KANSL3 MTSS2	1.15e-04	193	272	10	4225_DN
Drug	LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A	PPRC1 TSPYL2 KDM6B ARHGEF11 ZC3H7B RPS6KA4 PODXL2 MICALL1 HCFC1 MAST3	1.15e-04	193	272	10	1664_DN
Drug	alpha-Santonin [481-06-1]; Up 200; 16.2uM; PC3; HT_HG-U133A	HLF SH3GLB2 ZBED4 NPAP1 DMBT1 WDR62 POM121L2 HUWE1 KANSL3 BRF1	1.20e-04	194	272	10	4531_UP
Drug	Dibucaine [85-79-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A	TNFRSF25 PIDD1 ZBED4 NF2 ZFP36L1 ZC3H7B PLK3 BAHCC1 LHX6 HCFC1	1.20e-04	194	272	10	4149_DN
Drug	0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A	KCTD13 PTBP1 ZBED4 ZFP36L1 ZFP36L2 GLI2 ATN1 MICALL1 ARHGEF1 PCIF1	1.20e-04	194	272	10	4331_DN
Drug	Methocarbamol [532-03-6]; Down 200; 16.6uM; PC3; HT_HG-U133A	KCTD13 PIDD1 KDM6B ARHGEF11 ZFP36L2 IL17RA DMBT1 IBTK VCAN PCIF1	1.20e-04	194	272	10	2111_DN
Drug	chlorpromazine hydrochloride; Down 200; 1uM; PC3; HT_HG-U133A	TNFRSF25 ARHGAP32 KDM6B ARHGEF11 ITPR2 IL17RA PRRC2A SDC1 NUP214 MAST3	1.20e-04	194	272	10	1217_DN
Drug	Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A	PIDD1 SRCAP DYSF NFATC3 ZC3H7B PRR36 FOSL1 BRF1 MAP1S ZNF277	1.20e-04	194	272	10	3828_DN
Drug	Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; MCF7; HT_HG-U133A	TNFRSF25 SETD1B ARHGEF11 ZFP36L2 UNKL WDR62 RPS6KA4 LAMA2 HCFC1 ARHGAP33	1.20e-04	194	272	10	5303_UP
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; PC3; HT_HG-U133A	CDKN1C TSPOAP1 GLI2 ZC3H7B KALRN NRG2 BRF1 ZNF277 VCAN ARHGAP33	1.20e-04	194	272	10	4546_UP
Drug	Flumethasone [2135-17-3]; Up 200; 9.8uM; MCF7; HT_HG-U133A	TNFRSF25 PIDD1 NR4A1 RUNDC3A NFATC3 MAGEC1 PLK3 CACNA2D1 BRF1 TJAP1	1.25e-04	195	272	10	4734_UP
Drug	Hydralazine hydrochloride [304-20-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A	TNFRSF25 SETD1B PCDH12 SRCAP RUNDC3A LDLRAD4 NRG2 AIRE RAPGEF1 MTSS2	1.25e-04	195	272	10	4746_UP
Disease	mean corpuscular hemoglobin concentration	SETD1B LRRC37A2 ITPR2 FOCAD ZFP36L1 ZFP36L2 NFE2 HECW2 ADGRF5 TNS3 ZFAT ATN1 TTC28 KALRN DLGAP4 FBRSL1 MYPOP ELL2 BRF1 ABCA6 PRKAA1 PCIF1 MACF1 PKN2 MYB ARMH4	8.96e-06	1105	266	26	EFO_0004528
Disease	antihyperlipidemic drug use measurement	HGFAC CETP ARID1A RTL9 DOK7 FBRSL1 ABCA6 SP6	1.01e-05	115	266	8	EFO_0803367
Disease	triglycerides to phosphoglycerides ratio	HGFAC CETP ARID1A PCIF1 SP6 PCSK7	3.48e-05	68	266	6	EFO_0022327
Disease	Malignant neoplasm of breast	ERBB4 MYOD1 APC2 LRRC37A2 TNIP1 ARID1A DYSF LRRC37A NF2 MROH7 TREML1 PRRC2A FOXM1 KALRN LAMA2 TACC2 NUP214 SHROOM2 MICALL1 KMT2D ZNF277 PRKAA1 MACF1 ZBTB3	4.56e-05	1074	266	24	C0006142
Disease	mean platelet volume	ARHGAP32 SETD1B NACA SRCAP ZBED4 SSH1 ZFP36L1 NFE2 NFE2L1 GLIS2 ADGRF5 HOMEZ TTC28 KALRN PCDHGA11 FBRSL1 STIL FRY ARSA BRF1 ANKRD11 PCDHGA8 MYB	5.76e-05	1020	266	23	EFO_0004584
Disease	Intellectual Disability	KLF8 APC2 POGZ PCDH12 KDM6B WDR62 ATN1 PTPN23 LGI4 COL18A1 FRY BRF1 MACF1 RAI1	6.19e-05	447	266	14	C3714756
Disease	sexual dimorphism measurement	GAPVD1 KCTD13 CETP ARID1A DYSF TP53INP2 PTPRG GLI2 DOC2A FOXM1 ZFAT MARCHF9 DLGAP4 PTPN23 POM121L2 FOSL1 GPATCH3 PCIF1 SP6 ANKRD11 PCSK7 MACF1 LTBP3 NPAS4	7.19e-05	1106	266	24	EFO_0021796
Disease	phospholipids in medium LDL measurement	HGFAC CETP DOK7 ABCA6 PCIF1	7.91e-05	49	266	5	EFO_0022183
Disease	cholesterol in medium LDL measurement	HGFAC CETP DOK7 ABCA6 PCIF1	7.91e-05	49	266	5	EFO_0022224
Disease	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3	ZFAT TG	8.10e-05	2	266	2	608175
Disease	Autoimmune thyroid disease, susceptibility to, 3	ZFAT TG	8.10e-05	2	266	2	cv:C1842444
Disease	Acute Basophilic Leukemia	GATA1 MYB	8.10e-05	2	266	2	C0023437
Disease	eosinophil count	ST20-AS1 GATA1 TNIP1 PTBP1 KDM6B DYSF RUNDC3A ZFP36L1 ZFP36L2 NFE2 IL17RA ZC3H7B LDLRAD4 BAHCC1 ZFAT ARHGEF18 SEC31A PHC1 FOSL1 TG KANSL3 ANKRD11 GSDMA PKN2 LTBP3 TNFRSF1A MAST3 RAI1 MYB	8.53e-05	1488	266	29	EFO_0004842
Disease	reaction time measurement	HLF LRRC37A2 DYSF ARID5B GTPBP3 LDLRAD4 CACNA2D1 ZFAT TTC28 FBRSL1 TACC2 CACNA2D4 KMT2D GIGYF2 GSDMA PAX4 RAI1	1.12e-04	658	266	17	EFO_0008393
Disease	urate measurement, bone density	ERBB4 RC3H1 ITPR2 PTPRG GLI2 GLIS2 ARID5B DMBT1 FAM135A LDLRAD4 TTC28 FBRSL1 SEC31A DNAH1 TG ANKRD11	1.76e-04	619	266	16	EFO_0003923, EFO_0004531
Disease	very low density lipoprotein particle size measurement	HGFAC CETP ARID1A FOXM1 PCIF1 SP6 PCSK7	2.12e-04	133	266	7	EFO_0008594
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	HGFAC MAP1A CETP DBP ARID1A ABCA6 PCIF1 SP6 PCSK7	2.12e-04	224	266	9	EFO_0004574, EFO_0008317
Disease	phospholipids in large VLDL measurement	HGFAC CETP ARID1A PCIF1 SP6	2.44e-04	62	266	5	EFO_0022169
Disease	total lipids in very large VLDL measurement	HGFAC CETP ARID1A PCIF1 SP6	2.44e-04	62	266	5	EFO_0022313
Disease	testosterone measurement	HGFAC DCHS2 KLF8 MAP1A HLF KDM6B SRCAP ARID1A TP53INP2 CEP68 PTPRG ZFP36L1 RTL9 ARID5B SDC1 TNS3 FOXM1 CACNA2D1 TTC28 DOK7 DLGAP4 ARHGAP9 MYPOP MACF1 RAI1	2.44e-04	1275	266	25	EFO_0004908
Disease	attention deficit hyperactivity disorder, schizophrenia	ARID5B TSNARE1 PPP1R13B GIGYF2 RAI1	2.83e-04	64	266	5	EFO_0003888, MONDO_0005090
Disease	Adenoid Cystic Carcinoma	KDM6B SRCAP ARID1A ARID5B VCAN MYB	2.98e-04	100	266	6	C0010606
Disease	Autosomal recessive primary microcephaly	WDR62 STIL PHC1	3.04e-04	15	266	3	cv:C3711387
Disease	total lipids in large VLDL	HGFAC CETP ARID1A PCIF1 SP6	3.51e-04	67	266	5	EFO_0022175
Disease	free cholesterol in large VLDL measurement	HGFAC CETP ARID1A PCIF1 SP6	3.76e-04	68	266	5	EFO_0022265
Disease	Autoimmune thyroiditis	ZFAT TG	4.80e-04	4	266	2	C0920350
Disease	Schwannomatosis	NF2 COQ6	4.80e-04	4	266	2	C1335929
Disease	Neurofibromatosis, Type 3, mixed central and peripheral	NF2 COQ6	4.80e-04	4	266	2	C2931480
Disease	triglyceride measurement, coronary artery disease	SETD1B FBRSL1	4.80e-04	4	266	2	EFO_0001645, EFO_0004530
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	HGFAC CETP DNAH1 ABCA6 PCIF1 SP6 PCSK7 MACF1	4.89e-04	200	266	8	EFO_0004611, EFO_0020945
Disease	platelet component distribution width	GAPVD1 HLF PTBP1 CEP68 ZFP36L1 NFE2 NFE2L1 ADGRF5 PRRC2A KALRN MICALL1 COL18A1 TADA1 BRF1 MACF1 PKN2 MYB	5.47e-04	755	266	17	EFO_0007984
Disease	C-reactive protein measurement	HGFAC DCHS2 ERBB4 KCTD13 MAP1A CETP MCM2 TNIP1 PTBP1 SSPOP TP53INP2 PPP1R37 SLC27A3 TSNARE1 FOSL1 MYPOP ABCA6 PCIF1 MACF1 RORC TNFRSF1A ARHGAP33 ARMH4	6.34e-04	1206	266	23	EFO_0004458
Disease	Neurofibromatosis 3	NF2 COQ6	7.95e-04	5	266	2	C0917817
Disease	lymphocyte count	TNIP1 DBP ARHGEF11 NUFIP1 ITPR2 FOCAD ZFP36L1 ZFP36L2 SUPV3L1 ARID5B DMBT1 ZC3H7B ZFAT TTC28 KALRN PCDHGA11 ARHGEF18 ARSA SP6 ANKRD11 PKN2 LTBP3 TNFRSF1A PCDHGA8 RAI1 MYB	8.11e-04	1464	266	26	EFO_0004587
Disease	Gastrointestinal Stromal Sarcoma	STK36 GLI2 GLIS2 C2CD3	8.49e-04	47	266	4	C3179349
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	HGFAC CETP DBP ARID1A ABCA6 PCIF1 SP6 PCSK7	9.10e-04	220	266	8	EFO_0004529, EFO_0008317
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	HGFAC CETP MYPOP ABCA6 PCIF1 SP6 PCSK7 MACF1	9.65e-04	222	266	8	EFO_0008317, EFO_0020943
Disease	Autosomal Recessive Primary Microcephaly	WDR62 STIL PHC1	9.83e-04	22	266	3	C3711387
Disease	Primary microcephaly	WDR62 STIL PHC1	9.83e-04	22	266	3	C0431350
Disease	total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement	SETD1B TP53INP2 CEP68 FBRSL1	9.95e-04	49	266	4	EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612
Disease	hepatocellular carcinoma (implicated_via_orthology)	NFE2L1 FOXM1 POLG COL18A1	9.95e-04	49	266	4	DOID:684 (implicated_via_orthology)
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	HGFAC CETP ARID1A DNAH1 PCIF1 SP6 PCSK7 MACF1	1.02e-03	224	266	8	EFO_0004530, EFO_0008317
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	HGFAC CETP DBP ARID1A ABCA6 PCIF1 SP6 PCSK7	1.05e-03	225	266	8	EFO_0008317, EFO_0010351
Disease	Gastrointestinal Stromal Tumors	STK36 GLI2 GLIS2 C2CD3	1.07e-03	50	266	4	C0238198
Disease	feeling nervous measurement	TP53INP2 PLEKHM1 ZC3H7B CACNA2D1 TSNARE1	1.16e-03	87	266	5	EFO_0009597
Disease	acute lymphoblastic leukemia (implicated_via_orthology)	HLF DBP	1.19e-03	6	266	2	DOID:9952 (implicated_via_orthology)
Disease	myelofibrosis (implicated_via_orthology)	GATA1 MYB	1.19e-03	6	266	2	DOID:4971 (implicated_via_orthology)
Disease	total lipids in medium LDL	HGFAC CETP ABCA6 PCIF1	1.24e-03	52	266	4	EFO_0022180
Disease	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	ZFP36L2 NUP214 STIL MYB	1.34e-03	53	266	4	C1961099
Disease	triglycerides in medium VLDL measurement	HGFAC CETP ARID1A PCIF1	1.53e-03	55	266	4	EFO_0022155
Disease	triglycerides in very large VLDL measurement	HGFAC CETP ARID1A PCIF1	1.64e-03	56	266	4	EFO_0022325
Disease	hepatocyte growth factor activator measurement	HGFAC DOK7	1.65e-03	7	266	2	EFO_0008152
Disease	free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	HGFAC CETP POLR2M ARID1A ZFP36L1 ABCA6 PCIF1 SP6 PCSK7	1.82e-03	303	266	9	EFO_0004612, EFO_0020945
Disease	birth weight, parental genotype effect measurement	NFILZ ITPR2 SUPV3L1 CCDC201 RPS6KA4 USF3 RAI1	1.86e-03	192	266	7	EFO_0004344, EFO_0005939
Disease	apolipoprotein A 1 measurement	HGFAC MAP1A CETP ARID1A TP53INP2 MGAT1 ZFP36L1 NFATC3 MUC17 DOK7 FBRSL1 COL18A1 ABCA6 PCIF1 SP6 PCSK7 MACF1	1.92e-03	848	266	17	EFO_0004614
Disease	melanoma	CDKN1C ERBB4 NF2 NPAP1 CRYBG1 MAGEC1 PAX4 RAI1	1.94e-03	248	266	8	C0025202
Disease	triglycerides in VLDL measurement	HGFAC CETP ARID1A PCIF1	1.99e-03	59	266	4	EFO_0022326
Disease	triacylglycerol 54:7 measurement	MAGEC1 CACNA2D4 PLPP4	2.01e-03	28	266	3	EFO_0010425
Disease	triglyceride measurement, alcohol drinking	HGFAC CETP ARID1A PCIF1 SP6	2.06e-03	99	266	5	EFO_0004329, EFO_0004530
Disease	atrial fibrillation	ERBB4 NACA POLR2M ITPR2 CEP68 CRAMP1 ZFAT FBRSL1 CELA3B PKN2	2.11e-03	371	266	10	EFO_0000275
Disease	triglyceride measurement, phospholipid measurement	HGFAC CETP DNAH1 PCIF1 SP6 PCSK7	2.15e-03	146	266	6	EFO_0004530, EFO_0004639
Disease	Embryonal Rhabdomyosarcoma	MYOD1 ARID1A	2.19e-03	8	266	2	C0206656
Disease	mesangial proliferative glomerulonephritis (biomarker_via_orthology)	NR4A1 RAPGEF1	2.19e-03	8	266	2	DOID:4783 (biomarker_via_orthology)
Disease	Pena-Shokeir syndrome type I	MYOD1 DOK7	2.19e-03	8	266	2	C1276035
Disease	triglyceride measurement, alcohol consumption measurement	HGFAC CETP ARID1A PCIF1 SP6	2.25e-03	101	266	5	EFO_0004530, EFO_0007878
Disease	triglycerides in small VLDL measurement	HGFAC CETP ARID1A PCIF1	2.25e-03	61	266	4	EFO_0022145
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	HGFAC CETP PCIF1 PCSK7	2.25e-03	61	266	4	EFO_0008317, EFO_0008596, EFO_0020946
Disease	alkaline phosphatase measurement	MAP1A IST1 TNIP1 PLEKHM1 SLC12A9 NFATC3 GLIS2 PPP1R37 DMBT1 LDLRAD4 HOMEZ B4GALNT4 DOK7 ABCA6 PCIF1 GSDMA MACF1 LTBP3 RAI1	2.29e-03	1015	266	19	EFO_0004533
Disease	Drugs used in diabetes use measurement	KLF8 CCDC9B TP53INP2 UNC5C SP6 MACF1 LTBP3 PAX4	2.31e-03	255	266	8	EFO_0009924
Disease	phospholipids in very large VLDL measurement	HGFAC CETP ARID1A PCIF1	2.39e-03	62	266	4	EFO_0022299
Disease	cholesteryl ester measurement	HGFAC CETP ARID1A DOK7 ABCA6 PCIF1 SP6 PCSK7	2.42e-03	257	266	8	EFO_0010351
Disease	very low density lipoprotein cholesterol measurement	HGFAC CETP DBP ARID1A ABCA6 PCIF1 SP6 PCSK7	2.60e-03	260	266	8	EFO_0008317
Disease	asthma, response to diisocyanate	CETP POLR2M NUFIP1 GLI2 CACNA2D1 ZFAT VCAN GIGYF2	2.66e-03	261	266	8	EFO_0006995, MONDO_0004979
Disease	triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement	HGFAC CETP DNAH1 PCIF1 SP6 PCSK7 RAI1	2.76e-03	206	266	7	EFO_0004612, EFO_0020947
Disease	handedness	LRRC37A2 TTC28 ARHGEF1 PAX4 NPAS4	2.77e-03	106	266	5	EFO_0009902
Disease	lung cancer (implicated_via_orthology)	CDKN1C FOXM1	2.80e-03	9	266	2	DOID:1324 (implicated_via_orthology)
Disease	fibrinogen measurement, coronary artery disease	HGFAC DCHS2 ZFP36L1 DOK7 ARSA MAP1S	2.81e-03	154	266	6	EFO_0001645, EFO_0004623
Disease	cholesterol in large VLDL measurement	HGFAC CETP ARID1A PCIF1	2.84e-03	65	266	4	EFO_0021902
Disease	cholesterol in very large VLDL measurement	HGFAC CETP ARID1A PCIF1	2.84e-03	65	266	4	EFO_0022230
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	HGFAC CETP FOXM1 ABCA6 PCIF1 SP6 PCSK7 MACF1	2.86e-03	264	266	8	EFO_0008317, EFO_0020944
Disease	apolipoprotein A 1 measurement, apolipoprotein B measurement	CETP ARID1A ABCA6 SP6 PCSK7	2.89e-03	107	266	5	EFO_0004614, EFO_0004615
Disease	apolipoprotein B measurement	HGFAC DCHS2 CETP IST1 ARID1A PPP1R37 CACNA2D1 DOK7 DUSP4 ABCA6 PCIF1 SP6 PCSK7 EIF3G	2.98e-03	663	266	14	EFO_0004615
Disease	lymphocyte percentage of leukocytes	TSPOAP1 TNIP1 PTBP1 ARID1A ZFP36L2 ARID5B IL17RA ZC3H7B TTC28 ARHGEF18 GSDMA TNFRSF1A MYB CXCR2	3.06e-03	665	266	14	EFO_0007993
Disease	corneal topography	PKD1L1 ARID5B STIL NHSL1 ADAMTS7	3.13e-03	109	266	5	EFO_0004345
Disease	fibrinogen measurement	HGFAC DCHS2 ZFP36L1 DOK7 ARSA	3.13e-03	109	266	5	EFO_0004623
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement	HGFAC CETP PCIF1 SP6 PCSK7	3.13e-03	109	266	5	EFO_0004639, EFO_0008317, EFO_0008596
Disease	total lipids in small VLDL	HGFAC CETP DBP PCIF1	3.17e-03	67	266	4	EFO_0022148
Disease	lipid measurement, high density lipoprotein cholesterol measurement	HGFAC MAP1A CETP ARID1A PCIF1 SP6 PCSK7 RAI1 ARMH4	3.22e-03	330	266	9	EFO_0004529, EFO_0004612
Disease	cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	HGFAC CETP PCIF1 SP6 PCSK7	3.25e-03	110	266	5	EFO_0008317, EFO_0008596, EFO_0010351
Disease	chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement	HGFAC CETP PCIF1 SP6 PCSK7	3.25e-03	110	266	5	EFO_0004574, EFO_0008317, EFO_0008596
Disease	QT interval, particulate matter air pollution measurement	ERBB4 ARSA	3.47e-03	10	266	2	EFO_0004682, EFO_0008255
Disease	alpha wave measurement, electroencephalogram measurement	TNS3 DNAH1	3.47e-03	10	266	2	EFO_0004357, EFO_0006870
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	HGFAC CETP ARID1A ABCA6 PCIF1 SP6 PCSK7	3.49e-03	215	266	7	EFO_0008317, EFO_0008591
Disease	chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	CETP PCIF1 MAST3	3.53e-03	34	266	3	EFO_0008317, EFO_0008596, EFO_0020947
Disease	Kartagener Syndrome	STK36 FOXJ1 DNAH1	3.83e-03	35	266	3	C0022521
Disease	Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus	STK36 FOXJ1 DNAH1	3.83e-03	35	266	3	C4551906
Disease	total lipids in small HDL measurement	HGFAC CETP PCIF1	3.83e-03	35	266	3	EFO_0022311
Disease	free cholesterol in small HDL measurement	HGFAC CETP PCIF1	3.83e-03	35	266	3	EFO_0022270
Disease	Polynesian Bronchiectasis	STK36 FOXJ1 DNAH1	3.83e-03	35	266	3	C4317124
Disease	cardiomyopathy (implicated_via_orthology)	ERBB4 JPH4 DOC2A COL18A1	3.91e-03	71	266	4	DOID:0050700 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
PVLATTEALASPGPD	PTPRG	551	P23470
LLASPPAASAPSARD	TMEM59L	16	Q9UK28
AAAPSLEAPKPSGLE	KCTD13	11	Q8WZ19
STSTCLPPEPDSLLG	AMOTL2	736	Q9Y2J4
GLPAAATAASVIPLP	FAM222A	171	Q5U5X8
ETELVEPLTPSGTAP	ERBB4	691	Q15303
ALPASSLVLPGHPAD	FBRSL1	391	Q9HCM7
AATINLGDLPSDSPP	BAHCC1	1296	Q9P281
SLGPPPVASALSRAD	RNF40	621	O75150
TPGVSLHPLSLDSPD	ARHGEF1	321	Q92888
PNSPDLKLSDSDIPG	ARHGEF18	946	Q6ZSZ5
DLPLPTFSPTLLGDS	CETP	261	P11597
LPPPLLSAGASRESA	C9orf50	101	Q5SZB4
LATGDTSPEPELLPG	EIF3G	36	O75821
SEKSAAGLPLPPAAA	ELL2	356	O00472
DGRPLFPTSLEPTSD	CCDC116	331	Q8IYX3
PSLEGALPPDLDTSE	ANKRD11	1901	Q6UB99
PAEPGLVEAATAPSS	C6orf226	81	Q5I0X4
LSDTGAEGPTVAPLP	VCAN	2336	P13611
EATALPFSGPREPSL	CEP68	361	Q76N32
SLGPGPAPDTDTLSL	SH3BP5L	321	Q7L8J4
AALGLSSPSPDSPDA	DUSP8	431	Q13202
AEELSPAALSPSLEP	ARHGEF5	441	Q12774
PSISPALPALEASSE	ARMH4	571	Q86TY3
LDVLEPGSSPSDPTD	GSDMA	61	Q96QA5
AAVCGDPSTDPPLLT	GTPBP3	416	Q969Y2
SPVLLLDEPSTGIDP	ABCA6	1431	Q8N139
LPRPQSPSDLDSLDG	ATN1	96	P54259
ETLILTPPPGTAGLD	AJM1	871	C9J069
DGSLSPPAKEPLASD	ARHGEF11	1476	O15085
AEELSPAALSPLLEP	ARHGEF35	441	A5YM69
AALAAEPSPLPGSLI	C1orf131	66	Q8NDD1
GELISDEAPSIPAPT	CAMTA2	511	O94983
FLPSGPIALLPLSDT	COQ6	251	Q9Y2Z9
GTDLAETAPPPLCAS	BTBD11	771	A6QL63
DNSDPALEASSLPPP	DLGAP4	766	Q9Y2H0
APADGSTVESLPRPL	PPP1R13B	656	Q96KQ4
DGPTTLGPLDLLPSE	GRAMD1A	326	Q96CP6
DTPIGAPDLGLPSLS	ADAMTS7	1161	Q9UKP4
PSAAPLPGLDSSALH	AIRE	401	O43918
PSPGLALVPDLNDSL	MROH7	51	Q68CQ1
PSALDSADLPPPSAL	NFE2L1	581	Q14494
DHLSSSAPGSPPDLL	RC3H1	526	Q5TC82
PPAREESLLGAPSES	RASSF7	321	Q02833
STADFGDLPLLPPTS	RAI1	846	Q7Z5J4
ASGPSDVLLTPTADP	NFILZ	226	A0A5F9ZHS7
SLPPELADLSHSSGP	TSPOAP1	726	O95153
PLGAPEDIDLTPLSS	CYP2F1	461	P24903
PPGTRLLTVTASDPD	PCDHGA8	256	Q9Y5G5
PALPTDGSTGVELAP	PCDHGA11	566	Q9Y5H2
EAPSSGPPSSSLELL	PTPN23	1566	Q9H3S7
GPPSSSLELLASLTP	PTPN23	1571	Q9H3S7
ASGSPDTLLPSAIVP	ITPR2	1011	Q14571
PSTGLALDRLSAPDP	PCDH12	1041	Q9NPG4
LIDFGPEAPTSSPLE	KIAA0513	11	O60268
PLELSGSISSPSEAP	KIAA1549	631	Q9HCM3
DALTSSPGRDLPPFE	MCM2	36	P49736
DLASPEAAPAAPTAL	NR4A1	36	P22736
PSSLPDLSGSIDDLP	ARID1A	636	O14497
ENLPELAESSLPAGP	HECW2	531	Q9P2P5
EAALLPSGLPLEETP	MDGA1	481	Q8NFP4
LLPTGLEPLDSEEPS	PODXL2	51	Q9NZ53
PELPAAVDLSSTGEP	HCFC1	1541	P51610
LTSPLSPGVPEARAS	MUC16	306	Q8WXI7
SGASFPTLLPDTPAI	MUC16	2636	Q8WXI7
VSAVSEPGLLSLPPE	FBXW9	71	Q5XUX1
VLFLPVDPEDSPLGS	IL17RA	716	Q96F46
PAEGTPASTRPLLDF	PTPRN	876	Q16849
SLTEVTGPPTELEPA	LRRC37A3	786	O60309
SPESLPGPALEDIAI	MAP1A	1326	P78559
LPTLSDSDPVPLAPG	MAP1S	791	Q66K74
SAPEGEDSLSPLQIP	MAGEC1	681	O60732
SLTEVTGPPTELEPA	LRRC37A2	786	A6NM11
SLTEVTGPPTELEPA	LRRC37A	786	A6NMS7
RPPSVSALDGDPASL	MGAT1	36	P26572
VPAALSASALPGPDD	FAM149A	371	A5PLN7
SDSSGFLEEPLEPLP	ITPRID1	421	Q6ZRS4
SGLEPRTSLAPEPSL	GPR179	2316	Q6PRD1
ALSLLAGTVPSEPPS	CRB2	26	Q5IJ48
PEGNHISDLPLLDSP	IBTK	1251	Q9P2D0
APSAPALSTPGIRDS	LAT	176	O43561
LGPDRFSTLTDDPSP	GAPVD1	1006	Q14C86
TAEPADSGTERLLPP	KDM6B	941	O15054
PAAAPPALIEGSATE	JPH4	266	Q96JJ6
SPQEPDLAPLDLSLG	CCDC9B	411	Q6ZUT6
LSAPSDPLDIVVTGP	KIR3DL1	206	P43629
DLDPHSPGEPALLSL	NHSL1	486	Q5SYE7
SSLPPLPIECSELDG	FAM135A	386	Q9P2D6
APNSALIPTDPAAEG	GPATCH3	61	Q96I76
TESRGPPTTSDLLAP	PCSK7	736	Q16549
LNLTLSDPGDRPSSP	ITGA3	856	P26006
PISTPELLTPCGSAE	MKNK2	241	Q9HBH9
ETASPLAPDLAKASP	MTSS2	621	Q765P7
TESPAAPALLLADVP	MYOD1	261	P15172
ETPVGPLALAGPSST	COL18A1	146	P39060
SSTLPPFLLDAAPCE	CXCR2	26	P25025
LLLPESLPGSSASVP	HES3	141	Q5TGS1
SLGSLPASPFRIPED	NRG2	696	O14511
TERSPPLEGLVPSSA	KALRN	1691	O60229
PADLIPLEVPTGASS	POLG	241	P54098
TLPADGGPAAITVPL	KLF8	191	O95600
LPSPEEGTSIAAVPA	MACF1	851	O94854
KLDASAAAAPASLPP	NUP214	446	P35658
PRATSLPSLDTPGEL	DOK3	326	Q7L591
SGAPPSRLPSALSDD	LHX6	286	Q9UPM6
EEAPAAPSLATSPAL	MICALL1	436	Q8N3F8
PPALSGSPVISDISL	GLI2	86	P10070
ISLINGRPSADDPSP	LAMA2	216	P24043
SSPPLRTPDVLESSG	RPS6KA4	681	O75676
SLPADPGSLPEESAS	MYB	356	P10242
GPTAALPGPSDLLTD	TEPSIN	366	Q96N21
APLPNVTLDGFDLSP	ARSA	346	P15289
APLVDLSLSPPSGLD	GLIS2	76	Q9BZE0
EPDPADLALSSIPGQ	HLF	176	Q16534
ASSTSVDDALPLPLP	ARHGAP32	1446	A7KAX9
SPDLLATLPEPASPG	HGFAC	376	Q04756
LGLPNLPIDFPTSAA	HUWE1	806	Q7Z6Z7
SPAEPLLSRAGFSPD	MED26	361	O95402
ERPTADSAPSLPLEG	PLPP4	251	Q5VZY2
SEGPAASPPLAAAES	CRACDL	506	Q6NV74
LPPPGALDALSLSSS	MARCHF9	86	Q86YJ5
LPPDIPSFNLIGDSL	NF2	491	P35240
LPADSSSPAVAPDLF	MOGS	81	Q13724
GSVPTAALPALEPLG	PAX4	261	O43316
LPGSSSPLEPLDLVL	DCHS2	236	Q6V1P9
SPSLPPAGAIDTRDT	PPP1R37	601	O75864
TPLGSAEAIPLAPGI	MYO15B	731	Q96JP2
EPLDSNLSLSGAGPP	NPAS4	666	Q8IUM7
PVAVAGPSTPLEADL	REEP6	186	Q96HR9
SPASPAALDISEPLA	ARHGAP33	786	O14559
LSPDLLTLGPALPSS	GATA1	141	P15976
TAEPSFPEIPLDGTL	GASK1B	76	Q6UWH4
TPLIFVLSPGTDPAA	DNAH1	3671	Q9P2D7
TLPATALPLRGSTPE	APC2	2161	O95996
PIDPSFSLINILGDP	DNAH6	3031	Q9C0G6
SDISPSTSLPPLVEG	C2CD3	21	Q4AC94
DVISDPLGLNATPLP	PCIF1	81	Q9H4Z3
LAPPAALLGATTPED	DOC2A	61	Q14183
DLPLDTTTPGPALEQ	GIGYF2	711	Q6Y7W6
APLPSRTLFPSLEGD	POLR2M	96	Q6EEV4
SLLIGPSSEEPFPSA	CACNA2D1	16	P54289
SPPLEPAAESLDGLE	CDKN1C	116	P49918
GASDTSASPPLLLLP	CACNA2D4	1111	Q7Z3S7
PGSDPPAELHLSLSE	DMBX1	171	Q8NFW5
TPSPSAGPELLALLE	GGT6	311	Q6P531
SDPSVPTPSDILGLE	C3orf20	56	Q8ND61
FLEPAPAPGAAVLSS	CENPT	416	Q96BT3
DVSALLDISLPGPPE	CRAMP1	1071	Q96RY5
SDIFTGEPSLLPDSP	IL23A	106	Q9NPF7
ALEALELSPPLSPAS	FOXJ1	326	Q92949
PAGIADAPLSPLLTC	CENPN	311	Q96H22
LASLPPAGDILPNET	CELA3B	141	P08861
TGALSTGALPPLAPE	LTBP3	161	Q9NS15
LSPLSVPTAGSSPLD	MAST3	46	O60307
PGPVPASLSLALLES	DENND4B	1381	O75064
ASDPLPDPLGLMDLS	FOXM1	646	Q08050
LPSVPDTLPTASAGA	IST1	326	P53990
PAAKLPASPSGSEDL	KANSL3	516	Q9P2N6
AALPAATTPGPGLET	DBP	56	Q10586
DSRLLLPGSSPSSPE	FRY	1371	Q5TBA9
SSPAGLICLPPISEE	HOMEZ	36	Q8IX15
PLLELGGETTPPLST	CRYBG1	516	Q9Y4K1
SLLSLPAAGAPEPSL	DOK7	371	Q18PE1
PAPASASAPVLETLG	BSCL2	366	Q96G97
LDLSAPGEEPPTSAS	CCDC201	96	A0A1B0GTI1
PPVPTEGSESSLALR	DMBT1	221	Q9UGM3
VPPSATEPLDLGCSS	DUSP4	171	Q13115
SLSPEALLAISIPPG	SLC22A12	66	Q96S37
AGVDLSLTGLPPPVS	CEP131	16	Q9UPN4
LSAFPEPPEDGTLLS	CEP131	511	Q9UPN4
PSPTLPDLDVVADTG	DYSF	141	O75923
LLPTEPGTADPDATT	PKD1L1	971	Q8TDX9
SLPETPTGLADIPCL	PPRC1	781	Q5VV67
PLGAEDLLSDSSEPP	CNTROB	11	Q8N137
DELPGAPPVLCSSSS	CNTROB	621	Q8N137
AASPLGSPELCPSAL	FOCAD	1496	Q5VW36
GALLLALPPASPSAA	IRGQ	456	Q8WZA9
GDPSSDPLGSPTLLA	FOSL1	256	P15407
GEASPDAPSSPVAAL	PIDD1	296	Q9HB75
LPAAETPLALEPSSG	NFE2	196	Q16621
SPSLPGSLDSPVDIS	HOXA2	341	O43364
APSEGSPLLTSIPLS	MUC17	2096	Q685J3
PQGCLSPSDLLSEPA	PLEKHM1	651	Q9Y4G2
CLVSDSPEGSPALSP	RUNDC3A	431	Q59EK9
ALSPPLMPASDSGAL	RTL9	86	Q8NET4
PASDSGALSPLLMPA	RTL9	106	Q8NET4
ISESPEELGTPGPSL	RTN1	136	Q16799
APAGTTAIPGLIPDL	SYT8	26	Q8NBV8
PSPDDLPSRGLLALS	SYTL1	391	Q8IYJ3
SVPSGLAPALPLSAI	SZT2	801	Q5T011
SAGVPAPAPDSALDS	TRMT1L	31	Q7Z2T5
SPQDPSAGPLLTEEL	RPRD1B	166	Q9NQG5
PPSALAPASRTALEE	SSPOP	4541	A2VEC9
PTGLSPTLAPLLASE	SSPOP	4561	A2VEC9
SEGASLPAAASPERP	TMCO4	591	Q5TGY1
GGLSPSDELLPPLTH	TMEM151B	346	Q8IW70
LACSGDTLPASLPPV	TADA1	261	Q96BN2
EGSPDLPVSFSPTLL	LGI4	41	Q8N135
EASSPPSLPLSSALG	MAP3K21	786	Q5TCX8
GATPAEPEELLTPLA	POGZ	891	Q7Z3K3
DAAPALGPLSSSPLA	PRR36	291	Q9H6K5
LGAALASEPLPDPGT	GDF7	291	Q7Z4P5
SLTLPASAPGPEEAL	PRRC2A	1276	P48634
VPSVASLAPPGEASL	SH3GLB2	311	Q9NR46
PSDTALGALESLPPP	SHROOM2	496	Q13796
ALPPDPTARASLAAS	SHISA7	436	A6NL88
LTAIPTSPEPTGLEA	SDC1	71	P18827
STGLEDISPTPLPDS	SETD1B	566	Q9UPS6
SPRLSLPTDSLSPDG	RNF217	206	Q8TC41
VPGLPSLAPSLLAAA	SCRIB	981	Q14160
ELLNLPGAPESSLPH	SKIV2L	31	Q15477
LESDSPLAPGPFSKL	SP6	81	Q3SY56
TEPPSPDAGELSLAS	SUPV3L1	721	Q8IYB8
AAPTTFGSLDELAPP	NUAK2	516	Q9H093
PAPPRASSLGEIDES	PKN2	576	Q16513
GLELPPSAASDEPLQ	SRCAP	2651	Q6ZRS2
ELSTGPSPGSPTLDI	TNS3	681	Q68CZ2
ELSLAEPPDSLAPPS	TNS3	1001	Q68CZ2
SAPLPIPDLADLATG	NPAP1	421	Q9NZP6
PSTSPEDVIALAGLP	POM121L2	131	Q96KW2
ALSAPAEVRLTPPGS	STK36	831	Q9NRP7
DSRSPGVPLLPDTST	ROBO4	566	Q8WZ75
PPASPTLEVELGSAE	SH3RF1	736	Q7Z6J0
DPLLPSPEDETGSLV	SSH1	516	Q8WYL5
EEASAPATLPASPAG	THAP7	151	Q9BT49
TSLDSSPVDLTPRPG	PRKAA1	526	Q13131
GELLDSLEPTEAAPP	B4GALNT4	441	Q76KP1
LMSPDSPDPSSLLGI	ADGRF5	996	Q8IZF2
PLAPEKDSALVPGAS	ARID5B	546	Q14865
LPDGLSQPDPVSADA	C11orf53	111	Q8IXP5
PSPSLGSFDPLAELT	TNIP1	76	Q15025
ESELLLPTEPDSGFP	TJAP1	466	Q5JTD0
LHLDLTAPIPGASPE	PLEKHG5	566	O94827
ATPTSELLPLGPVDG	PLEKHG5	796	O94827
AASGPAPVSLVETAP	PLK3	391	Q9H4B4
VGLDSLTPALPPLAE	PDCD11	1541	Q14690
LTPALPPLAESSDSE	PDCD11	1546	Q14690
DLDSGLLPTPEQTPL	SEMA6B	701	Q9H3T3
VSAPTGPLDPASAAD	SEMA6B	801	Q9H3T3
EITPTASLPGDFLIP	STIL	111	Q15468
ITPPPILSADDLLGS	ZFP36L1	226	Q07352
SNPAEASDLLPPVAG	ZFAT	676	Q9P243
PTESLEALPTPEASG	TSPYL2	111	Q9H2G4
ALPSEGFSLEPPRAT	TSNARE1	236	Q96NA8
GQLPLGSSPDLPEAS	RORC	156	P51449
ASPELTPTLGPLSDT	NUFIP1	16	Q9UHK0
SPSPLPDAALPDGDL	TP53INP2	121	Q8IXH6
GPPAEKPLEELSAST	REV1	1121	Q9UBZ9
LSPLPESLGESGSPF	RAPGEF1	411	Q13905
AAPLSPGATVALLLP	SLC27A3	161	Q5K4L6
PPDGFLSNSAPLELI	SAGE2P	446	A6NJ88
EGATSPVLASLEPPT	ST20-AS1	56	Q8NBB2
STGDASLPGPLTPVA	KIF21A	1176	Q7Z4S6
PESPSLDSALASPLD	TUT1	236	Q9H6E5
TLGDLDSLPSDPVQP	SLC12A9	566	Q9BXP2
SRQAPLPSPESLDLG	NFATC3	1056	Q12968
SLDPTVPISGPDDLS	PRRT4	291	C9JH25
VPISGPDDLSPPASL	PRRT4	296	C9JH25
DEALSPTSPGPLSVR	PHC1	891	P78364
TGTPEPLDPQGSLSL	ARHGAP9	281	Q9BRR9
ASKPSEASLLEGDPP	USF3	1161	Q68DE3
ELLLSGPPEVAAPDT	TACC2	1221	O95359
EAALSPLPPSVEDAG	PRRG4	171	Q9BZD6
ISLPTAPPAAGTESL	PRSS2	126	P07478
RALGPAAAPTLSPES	TNFRSF25	306	Q93038
PALGSLLDPLPTAAS	BRF1	406	Q92994
PARALPLGPASSTVE	UNKL	401	Q9H9P5
LASASELPLGSRPAP	ZNRD2	101	O60232
ELSLPEGPSVPSSSL	WDR62	1036	O43379
TETTSLGSLPLPAGP	TTC28	2436	Q96AY4
ILEPLSLPESPGGTT	ZNF277	36	Q9NRM2
TPPPAEGLEAASASL	TSPYL6	91	Q8N831
GAAPTLSVPTPDGAL	WNK2	2236	Q9Y3S1
PGTTGTLPAASELPA	SEC31A	971	O94979
VSDSGPAAELPLDVP	TREML1	216	Q86YW5
PGGLESPLLLDSPTS	ZFP36L2	271	P47974
TRPDLPSGDSQPSLD	PTBP1	276	P26599
PRPASPTEAGLTTEL	TG	1841	P01266
ADPILATALASDPIP	TNFRSF1A	321	P19438
SEEPTGIDLPLLDPA	UNC5C	816	O95185
VDPPSPRADTLLGSS	SPATA6	261	Q9NWH7
PNDEDSLPPLLVASG	ZFYVE16	1016	Q7Z3T8
ASPSALGELGLPVSP	UTF1	41	Q5T230
LAASVLDALDPPGPT	ZC3H7B	331	Q9UGR2
SLLLPPQPADAGDLS	ZBED4	186	O75132
PQPADAGDLSTILSP	ZBED4	191	O75132
VSLEPLPSLDVGPES	ZBTB3	291	Q9H5J0
DDSAPLPAGTLDQPL	AGL	1186	P35573
VPASSPESILGEEAP	KMT2D	4706	O14686
IDLPPTISLSDGEEP	LDLRAD4	166	O15165
LIGPPISPAALALAS	NACA	106	E9PAV3
LSALLPLLPGTPVDS	MYPOP	291	Q86VE0